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Summary 
Background 
The prevalence and burden of chronic diseases, including cancer, are escalating 
worldwide. New models of care are needed to combat this rising challenge. A growing body 
of evidence supports the effectiveness of eHealth interventions in providing self-management 
support and enabling online patient-provider communication. However, a number of barriers 
to achieve the full benefits of what eHealth can offer have been reported. 
Aims 
The main objective of this doctoral dissertation was to address gaps identified in the 
literature related to the uptake, use and effectiveness of eHealth interventions, especially: 1) 
the benefits and barriers to maintaining the use of eHealth interventions in clinical practice, as 
experienced by health care providers, 2) the need to better understand user characteristics and 
use patterns of patients who are offered eHealth interventions, and 3) the need to better 
understand which components can contribute to the effect of eHealth interventions. These 
gaps were addressed from different perspectives through three different studies. Study I 
(related to eHealth uptake) explored nurses’ experiences of benefits of and barriers to 
maintaining the use of an interactive tailored patient assessment tool, called Choice, in cancer 
care one year after implementation. Study II (related to eHealth use) explored user 
characteristics and use patterns associated with the use of different components of a web-
based self-management support system, called WebChoice, for patients with cancer. Study III 
(related to eHealth effectiveness) tested and compared in a randomized controlled trial (RCT) 
the effects of (a) a stand-alone secure e-mail service, (b) the secure e-mail service with 
additional features of WebChoice, a multi component system, and (c) usual care on: symptom 
distress, anxiety, depression, (primary outcomes), and self-efficacy (secondary outcome) after 
six month of system access. 
Methods 
This dissertation used a multi-method approach, employing both qualitative and 
quantitative methods that included interviews, secondary analyses of longitudinal data and a 
RCT. Study I had a qualitative design, in which 20 nurses participated in focus group 
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discussions about their experiences of using Choice in regular care. Analyses were performed 
using content analysis. Study II used secondary analysis of user characteristics and use 
patterns of 162 patients with breast or prostate cancer who had 12 months access to 
WebChoice in a previous RCT. Analyses were performed using logistic regression and latent 
class analysis. Finally, study III entailed a three-group randomized controlled trial in which 
167 breast cancer patients recruited from three hospitals in Norway were randomized to a 
nurse-administered secure e-mail service, or to the Web-based self-management support 
system WebChoice (which included the secure e-mail service) or to usual care. Analyses of 
primary and secondary study outcomes were performed using linear mixed models. 
Results 
In study I, which addressed the nurses’ perspectives about barriers and benefits related 
to the uptake of the interactive tailored patient assessment and communication tool Choice in 
regular care, three major themes important to maintaining use of Choice, were identified from 
transcripts of interviews with nurses. Choice was perceived as (1) facilitating shared 
understanding between patients and clinicians and facilitating patients’ engagement in their 
own care; 2) enhancing the patient’s own strengths; 3) yet also presenting new challenges for 
the nurses, such as organizational challenges, the need for communication training and ethical 
challenges (paper I). 
In study II, designed to improve the understanding of user characteristics and factors 
associated with the use of different eHealth components, high level of computer experience 
and no additional illnesses besides cancer increased the overall probability for patients with 
breast or prostate cancer to use the WebChoice intervention. Men with prostate cancer and 
women with breast cancer who had low scores on social support, accompanied by high levels 
of symptom distress and high levels of depression, were more likely to use the e-mail 
component. For men, these characteristics were also associated with high use of the self-
management advice component (paper II). 
Finally, in the randomized clinical trial in study III, focusing on effectiveness, the group 
who had access to all features in WebChoice reported significantly lower scores of symptom 
distress, anxiety and depression than the usual care group. About 40% of those with access to 
sending secure e-mails used this opportunity. The group with access to the secure e-mail only 
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reported significantly lower depression scores than the usual care group; no differences were 
observed in symptom distress or anxiety.  
Conclusion 
The results from this dissertation suggest that, from nurses’ perspectives, integration 
of an interactive tailored assessment tool such as Choice in clinical practice offers many 
benefits for communication and enhancement of patient-centered care that contribute to 
maintenance of use. However, to reap these benefits, use of such tools must receive equal 
priority to other routines and require sufficient time and competence.  
Further, this dissertation provides emerging evidence that different user characteristics 
are associated with different use patterns of Web-based self-management support. Such 
information is important in order to target Web-based support systems to different patient 
groups. In study II, secure e-mail and self-management advice were particularly used by 
patients who had low levels of social support and a high illness burden, suggesting that 
patients with these characteristics may find such tools particularly useful. 
Finally, this dissertation shows that a Web-based self-management system can be an 
important contributor in providing health care for breast cancer patients in terms of reduction 
of symptom distress, anxiety and depression scores. The secure e-mail component alone 
contributed to reduced depression scores, which indicates that secure e-mail is an important 
part of multi-component systems and can also effectively be offered as a stand-alone service. 
This is promising, as depression is highly prevalent and debilitating among cancer patients. 
An e-mail service is much easier to develop and to implement widely than more complex 
multi-component solutions. Despite the concerns identified in the literature regarding health 
care providers being flooded by messages, only modest use was observed in these studies, 
indicating e-mail as manageable to integrate in routine care. 
In summary, through materials from three different studies and use of multiple 
methods, this dissertation adds to the knowledge about the uptake, use and effectiveness of 
eHealth interventions in real life settings. The results and knowledge gained are important to 
the design of support systems that are better tailored to the individual and the context of use. 
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1. Introduction 
The burden of chronic diseases is expected to escalate worldwide [1,2] and the incidence of 
one of the leading chronic diseases, cancer, is rising dramatically [3]. In order to meet this 
challenge, new models for care are required. eHealth has become increasingly important in 
the delivery of self-management tools and health communication systems. A growing body of 
evidence supports the effectiveness of web-based self-management support interventions [4-
8] and electronic interventions to support patient-provider communication [9-11]. 
Barriers to realizing the benefits offered through eHealth interventions nevertheless still exist 
[12]. There is a large gap between research on eHealth interventions that have shown to be 
effective in clinical trials and eHealth implementation in regular clinical practice [13-15]. This 
dissertation seeks to address this issue through examining aspects of the Reach, Effectiveness, 
Adoption, Implementation and Maintenance (RE-AIM) framework [16], a widely used 
framework  to improve translation of health promotion interventions into practice. In 
particular, this dissertation, using multiple methods, addresses aspects related to uptake, use 
and effectiveness of eHealth interventions in real-life settings in the hospital and in patients’ 
homes, from the perspectives of patient and health care provider. 
The first aspect we addressed relates to the challenges associated with sustainable use and 
maintenance (i.e. uptake) of eHealth interventions in clinical practice (Study I) [17-19], the 
maintenance dimension in the RE-AIM framework. While a number of studies have addressed 
aspects of system implementation, few have examined factors related to sustained use and the 
challenges that may emerge over time after a new intervention has been implemented [20]. 
This dissertation contributes to knowledge in this area by exploring nurses’ experiences of an 
interactive tailored symptom assessment intervention (i.e. Choice) in routine practice one year 
after its implementation (Study I). 
The second aspect addressed in this dissertation is the need to better understand user 
characteristics and user patterns related to the use of eHealth interventions (Study II), the 
implementation dimension of the RE-AIM framework. Although many studies have shown 
eHealth interventions to be effective, users appear to use these interventions differently than 
intended [21,22]. Furthermore, while perceptions of a system’s perceived usefulness have 
been investigated in a number of studies, the systems have primarily been evaluated as a 
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whole on a set of general criteria. The usefulness of specific components that the system 
offers is seldom addressed. In order to design Web-based systems that can better target 
different user groups, more research is needed to examine which user characteristics are 
associated with use of different components of support [8]. This dissertation therefore adds to 
this knowledge through exploring the characteristics of different users and their use-patterns 
of a multi-component web-based self-management support system (WebChoice) in study II. 
Finally, study III addresses the effectiveness dimension of the RE-AIM framework. While 
eHealth interventions are often complex systems, consisting of several components, little is 
known about which components contribute to the observed effects [23,24]. We know little 
about how many components are needed to create an effect, or which components are 
particularly effective. In addition, little is known about the effects in clinical trials if parts of 
an intervention were offered as an integrated part of regular care. Testing of interventions in 
diverse settings increases external validity, an important factor in implementing complex 
interventions [25]. This dissertation contributes important information to the area through 
comparing, in three different settings, the effect on patients’ outcomes of the multi-component 
self-management support system WebChoice and a single secure e-mail component to usual 
care, when the interventions were integrated as a part of regular care (Study III). 
1.1 Specific aims 
The main objective of this dissertation was to address gaps identified in the literature related 
to uptake, use and effectiveness of eHealth interventions into practice from different 
perspectives. The specific aims were:  
I. To explore nurses’ experiences of benefits of and barriers to maintaining use of an 
interactive tailored patient assessment tool called Choice in cancer care, one year after 
its implementation (study I). 
II. To describe user characteristics and user patterns associated with the use of different 
components of a web-based illness management support system for cancer patients 
called WebChoice (study II). 
III. To test and compare the effects of (1) a secure e-mail service, (2) the multi-component 
WebChoice intervention (including the e-mail service), and (3) usual care on: 
symptom distress, anxiety, depression, (primary outcomes), and self-efficacy 
(secondary outcome) after 6 month of access (study III). 
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The RE-AIM framework, consisting of Reach, Effectiveness, Adoption, Implementation and 
Maintenance dimensions, was used as the conceptual framework to guide this dissertation 
[16]. RE-AIM is designed to improve the likelihood of translating health promotion 
interventions into practice [16,26]. It has been argued that to fully embrace the potential 
offered by eHealth, a continuous systematic evaluation is needed [27]. RE-AIM addresses 
important elements to consider in such an evaluation. To contribute with new knowledge to 
the evaluation of eHealth systems, this dissertation address three dimensions of the RE-AIM 
framework in particular; the maintenance, implementation and effectiveness dimensions. The 
reach and adoption dimensions are also addressed in the studies, but not to the same extent as 
the three other dimensions. More details of the RE-AIM framework are provided in Chaper 
2.6 Theoretical framework. A summary of aspects studied, aims, eHealth interventions, RE-
AIM dimension and methods used is displayed in Table 1. 
Table 1. Overview of aspects studied, aims, eHealth interventions, methods and RE-AIM 
dimensions addressed 
 
Study I Study II Study III 
 
Aspect studied Uptake Use Effectiveness 
Aim Explore nurses’ 
experiences of benefits 
and barriers of use and 
maintenance of Choice in 
regular care  
Explore user 
characteristics and 
patterns of use of different 
components 
Compare effectiveness of 
WebChoice and secure e-
mail vs usual care on 
patient outcomes 
eHealth intervention Choicea WebChoice 1.0b WebChoice 2.0b 
Secure e-mail 
Method Qualitative 
Focus groups 
Quantitative 
Exploratory 
Quantitative 
RCT 
RE-AIM dimension Maintenancec, 
Implementation 
Reach, Implementationc  Reach, Effectivenessc, 
Adoption, Implementation 
a Interactive tailored patient assessment system. 
b Web-based self-management support system, including communication components.  
cMain RE-AIM dimensions addressed 
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2. Background 
Recent improvements in detection, diagnosis, treatment and recovery allow people with 
cancer to live longer [28]. As such, cancer is seen as a chronic illness over a longer time. 
Longer life expectancy poses new challenges for patients and families related to self-
management and coping with the consequences of illness. It also challenges the way the 
health care system is organized in terms of long-term care for patients. Cancer and other 
chronic conditions are associated with considerable psychosocial burden and extensive costs 
for the health care system [1]. Increasing pressure to maintain or reduce health care costs 
leads to demands for more effective ways to provide information and self-management 
support for patients. Furthermore, patients increasingly want to be involved in their own care 
and the decisions made [29]. This presents both new opportunities and new demands for 
patients, their caregivers and the health care system. Society needs to offer ways to improve 
patients’ self-management capability as well as to offer systems that allow patients to take 
part in their own treatment and care. 
New technologies bring new opportunities for delivering health care, for health 
communication and for supporting self-management [30]. The development and use of 
eHealth interventions has become an emerging, rapidly evolving field [31]. The concept of 
eHealth came into use in 2000 [32], and has become one of the most frequently used terms 
recently [31]. Several definitions have been used to describe this concept and vary depending 
on the scope and stakeholders involved. A review by Pagliari et al. identified 36 different 
eHealth definitions [32]. In this dissertation the following definition of eHealth is used: “the 
use of emerging information and communication technology, especially the Internet, to 
improve or enable health and health care” [33, p.1]. This definition emphasizes eHealth’s 
potential to improve or enable health and health care, and includes both patients and health 
care providers.  
The importance of utilizing opportunities offered by eHealth has been highlighted by 
governments in different parts of the world in recent years. The World Health Organization 
strongly recommends implementing self-management support programs to enable persons 
with chronic illnesses such as cancer to manage their symptoms [34]. The European 
Commission has developed an action plan for digital solutions in Europe's health care systems 
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[12], with the goal of improving health care for the benefit of patients, giving patients 
increased control of their care and reducing health care costs. In this plan the European 
Commission also addresses barriers to full use of digital solutions, and acknowledges that 
digital health care has yet to fulfill its potential to improve health care and to generate 
efficiency savings [12].  
Thus, the potential of eHealth to improve health care is still not fully realized, even though 
there is political willingness to take advantage of new technologies. To increase utilization, 
there is a need to look at factors beyond effectiveness. This dissertation focuses on aspects 
related to uptake, use and effectiveness of eHealth interventions. In the following, a short 
summary of literature related to electronic symptom assessment and communication tools 
(interventions with similarities to Choice, used in Study I) and Web-based self-management 
systems (interventions such as WebChoice, used in Study II and III) are provided first. Next, 
literature specifically related to the aims of the dissertation will be presented, followed by a 
description of the theoretical framework that guides this dissertation. 
2.1 Electronic symptom assessment and communication tools 
In recent years a growing number of electronic symptom assessment and communication tools 
have been introduced in clinical practice [10,35,36]. In addition to helping patients report 
their symptoms, problems and concerns, such tools can support clinicians’ efforts to provide 
individually tailored support and follow-up [11,37]. Studies report significant effects of such 
tools on patient care by reducing symptom distress and patients’ need for symptom 
management support [11], reducing anxiety and depression scores [38], improving quality-of-
life outcomes [39,40], addressing patients’ symptoms [41,42] and disclosing patients’ cues 
and concerns in communication with clinicians [43-46]. 
Electronic symptom assessment tools are found to be feasible and well accepted by health 
care providers and patients [47-50], and to be easy for patients to use across a range of user 
characteristics [51-53]. Health care providers have reported these tools to be helpful in 
detecting, assessing and managing the patients’ symptoms [43,47,54,55]. Access to patients 
reported symptoms and quality of life issues are also reported to improve patient-provider 
communication by increasing the number of issues discussed during the intervention 
consultation [41,42,53].  
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Despite the recognition of effects and benefits of using electronic symptom assessment tools, 
concerns have also been noted. Concerns include patient burden resulting from the need to fill 
in their symptoms and problems, issues with the wording and formatting of the questions, and 
technical difficulties [55]. Physicians have raised concerns that such tools might increase their 
workload, and that it is a challenge to change their set of patterns of questioning and behavior 
during a medical consultation [53]. However, little is known about how these tools are used in 
regular care and how nurses, who are the providers highly involved in symptom management 
for patients, perceive the barriers and benefits. In addition, few studies have examined 
experiences of use over time (maintenance), or challenges that may emerge after 
implementing these interventions into practice. In study I, this dissertation therefore explored 
nurses’ perception of benefit and barriers of maintained use of Choice one year after 
implementation. 
2.2 Web-based self-management support 
Recent years have also seen a growth in Web-based systems to support self-management for 
people with chronic illness [6,56-59] and specific conditions such as asthma [60], diabetes 
[61-67], rheumatology [68,69], mental health [70-72], cardiac disease [73,74] and cancer 
[7,24,75-79] The purpose of such Web-based self management support systems is to 
contribute to better illness self-management for users.  
Self-management, a core concept in chronic care, in brief, refers to the actions individuals 
take to manage their own illness. Lorig defines self-management as “learning and practicing 
skills necessary to carry on an active and emotionally satisfying life in the face of a chronic 
condition” [80, p.11]. The aim of self-management is described as keeping wellness in the 
psychological foreground [81]. To be able to do so, as first described by Corbin and Stauss 
[82], a person has three self-management tasks to perform: 1) managing the medical aspects 
of the condition; 2) managing life roles, included changes in the roles due to the illness; and 
3) managing the emotions brought by the illness, such as anger, fear, frustration and 
depression. To perform these tasks, the person has to possess a set of self-management skills 
[81]. Self-management support involves helping patients and caregivers to achieve the 
necessary skills and confidence to cope and to manage the illness [83-85]. 
It is not enough just to tell patients what to do, as is often the norm. Patients’ central role in 
their own care has to be acknowledged to enable them to take responsibility for their own 
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health. eHealth interventions can contribute to increasing self-management capability, 
strengthening the roles of patients and users roles through their ability to provide and 
communicate information and knowledge, as well as being a channel for communication with 
other patients and health care providers [86]. Acknowledging patients’ ability to be a partner 
in their own care and offering systems that target the patients’ conditions can enable self-
management. 
Self-management support interventions delivered through the Internet have the potential to 
reach a large group of users because Internet access in the population increases worldwide 
every year [87]. In addition people regularly use the Internet to obtain health information [88-
90]. Web-based self-management support systems usually contain several components, such 
as illness-specific information/education, symptom monitoring, treatment instructions, self-
management training, decision support, peer support, communication between patients and 
health care providers though electronic messages and electronic diaries [8,91,92]. 
A number of advantages are known in connection with Web-based self-management systems, 
compared with more traditional ways to provide self-management support [8,31,93]. These 
include, among others, anonymity, convenience and flexibility for users, equity, increased 
access to reliable information, tailoring potential and interactivity. On the other hand, 
concerns have been raised regarding possible adverse effects such as patients receiving 
incorrect information or advice; patients making inappropriate decisions (as judged by health 
care providers); exclusion of users because of the digital divide; breakdown of the relationship 
between the patient and the health care provider; information overload among health care 
providers and breaches of users’ privacy [8,94]. To counterbalance some of these possible 
adverse effects, a prerequisite is to offer interventions of high quality through secure systems. 
Multiple studies have demonstrated the effects of Web-based self-management support 
interventions in chronic illnesses. A Cochrane review concluded that users tended to become 
more knowledgeable, feel more socially supported and were likely to have increased self-
efficacy [8]. Web-based self-management support interventions for people with chronic 
illnesses are reported to improve quality of life [66,73,95-98], self-management [73,99] and 
self-efficacy [56,58,65,66,95,100]. In addition, they have been found to increase patient 
activation [6,65], acceptance [57], social support [66], and knowledge [63,98], as well as to 
reduce depression [57,66,71], stress and loneliness [57]. In a review of Web-based 
interventions designed for cancer patients, Ventura et al [101] concluded that these 
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interventions are being used and are helpful to individuals regardless of their age, gender, 
literacy level and disease stage. Web-based interventions for cancer are also reported to 
reduce symptom distress [7,75,76], cancer-related fatigue [78], anxiety scores [78], and 
overall negative emotions [102], as well as to increase social support [102-104], quality of life 
[78,103], emotional processing and health information competence [24] and fighting spirit 
[77]. 
Web-based self-management support interventions are also shown to achieve similar 
improvement in knowledge, self-efficacy and self-care activities compared with face-to-face 
follow-up [105]. In a review of Web-based interventions for depression and anxiety disorders, 
the majority of studies demonstrated some evidence of effectiveness [106]. It was concluded 
that these interventions offer promise for use as self-help interventions or as an adjunct to 
usual care. However, there are also conflicting reports. In a recent review, Paul et al [23] 
concluded that although it was possible to achieve positive effects on psychosocial outcomes 
using web-based approaches, effects were not consistent across conditions. A well powered 
study of a Web-based diabetes self-management support program showed no significant 
differences in psychosocial outcomes at 12-month measurement [62]. Similarly, no effects 
were detected in a study including patients with multiple sclerosis [107]. These inconsistent 
findings highlight that users may benefit in different ways. Little is known about how specific 
diagnoses or characteristics among users contribute to impact, and which component 
combinations contribute to effects. To add to this knowledge, user characteristics, 
psychosocial outcomes and their relation to user pattern were explored in study II in this 
dissertation. In addition, effects of one single component and the whole WebChoice 
intervention were tested in study III to tease out the differences between single and multiple 
component interventions. 
2.3 Uptake of eHealth interventions in routine care 
A consistent finding from clinical and health services research is the failure to translate 
evidence into practice and policy [108]. Similar challenges are also evident in the field of 
eHealth [14,18,109-111]. While a number of studies have examined initial implementation 
efforts, little research has examined the maintenance of interventions or programs after they 
have been implemented [20]. In addition, there is limited evidence on how to effectively 
promote the maintenance of eHealth interventions by healthcare professionals [112]. 
9 
 
Therefore, nurses’ experiences of benefits of and barriers to an eHealth intervention that had 
been used in clinical practice for one year were explored in study I. 
2.3.1 Barriers to technology adoption and maintenance 
The published literature on factors that promote or inhibit eHealth implementation and 
maintenance is described focusing mainly on organizational issues and less on the wider 
social framework important to consider when introducing new technologies [18]. Typical 
organizational barriers noted are fear of, or experienced, additional workload [113-115], lack 
of financial reimbursement [110,113], costs [110,116], and lack of support [115]. Concerns 
regarding privacy, safety and confidentiality of digital information are also reported to 
influence implementation [116-118]. In addition, a fear that use of technology will 
dehumanize patient care [119] and concerns about whether the system actually benefits 
patients have been noted [120]. Issues regarding design and technical challenges of e-Health 
interventions are reported as barriers [114,119]. For instance, failure to develop interventions 
that consider patient or staff characteristics and needs in the design phase can inhibit 
implementation [121].  
Regarding the interaction between health care providers, differences in adoption of 
innovations between nurses and physicians are reported to create challenges in the 
implementation phase [54,118]. Resistance from one group may limit realization of an 
innovation’s full potential. If the system lacks functionality to encompass the perceived roles 
of all multidisciplinary team members, including physicians, this may also limit use [54]; 
attitudes within the clinical community, negative attitudes and resistance to change can also 
be barriers to use and implementation [19,121]. Introduction of technology into health care 
settings can be challenging for the existing culture because these organizations are often 
hierarchical and have a tradition of adopting evidence-based approaches based on lengthy trial 
periods [122]. This carries the risk of slow adoption of new technology, based on the fear of 
the consequences of failure. More research is however needed to address this issue. 
Among patients, lack of interest and concerns about privacy [117], technical difficulties such 
as login procedures as well as the time required to learn how to use the system [123,124] and 
staff resistance to using technology [125], are reported as barriers to implementation of 
eHealth interventions. 
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2.3.2 Facilitators and incentives for technology adoption and maintenance 
The interaction between the innovation, the intended adopter(s), a particular context and the 
manner in which the implementation process is carried out determines the adoption rate 
[25,126]. Most translation models suggest that planned knowledge translation for healthcare 
professionals and consumers is more likely to be successful if the choice of knowledge 
translation strategy is informed by an assessment of the likely barriers and facilitators [108]. 
One of the key elements to successfully implementing and maintaining change is to have an 
effective strategy for communicating the intent, design, testing and implementation of the 
technology involved. When key people feel informed, they are much more likely to support 
the change [126]. However, until eHealth interventions are ‘‘fit for purpose’’, health care 
professionals are unlikely to adopt them, which may create a risk of implementation failure 
[27]. 
Perception of the benefits of an innovation (system usefulness, ability to solve problems) is 
described as the most common facilitating factor influencing the adoption of information and 
communication technologies by healthcare professionals [114,127], followed by ease of use 
[114]. Benefits include both patient outcome [119] and workload improvements [128,129]. 
These factors are addressed in study I. Patients are also more likely to make use of beneficial 
and easy-to-use resources [122,125,130]. 
Key factors to make the systems useful are the involvement of users (both patients and 
providers) in development and implementation phases, support from leaders, use of project 
champions or other key staff, providing adequate training and support, and monitoring system 
use in the early stages of implementation [114,116,119]. 
Interventions that fit into the existing workflow, routines and culture are more likely to be 
adopted [127,128,131,132]. To facilitate implementation of new interventions, one may 
require a redesign of internal processes [110,127,133]. In addition, significant resources and 
expertise, as well as user training among patients and providers, are required to implement 
eHealth interventions [36,134].For secure e-mail communication, integration with 
reimbursement systems, triage, and initial uptake by larger health-care organizations are 
expected to speed up the adoption into routine health care [135].  
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Initial concerns about integration of eHealth interventions can sometimes be overcome by 
simply exposing providers to this process [136]. In a service offering e-mail as a method of 
communication between nurses and patients with lung cancer, nurses expressed concerns 
prior to the study but were extremely positive about e-mail service after the study [137], and 
e-mail was found to be useful and convenient, with advantages outweighing any 
disadvantages. A similar observation was made in a survey to determine the methods of 
remote symptom assessment that cancer outpatients would be comfortable using; most 
patients reported that they did not feel comfortable using technology such as a secure website, 
email, or mobile phone text message [138]. However, studies examining the acceptability of 
these new methods after patients have used them report greater acceptability [49,52]. 
Therefore, studying maintenance of eHealth interventions used in regular care is essential, 
such as in study I, in order to increase knowledge about these factors. 
Implementing and maintaining eHealth interventions is more than simply putting technologies 
in place. It requires new resources and considerable effort [139] and it creates culture change 
[128]. This takes time, active engagement and patience. To better understand why a given 
technology is successful or not is in itself a topic for further research [140]. There is 
increasing recognition that the extent to which new programs are maintained is influenced by 
many different factors [20].  
2.4 User characteristics and use pattern of eHealth interventions 
Although eHealth interventions are shown to be effective, varying levels of user adherence, 
non-usage attrition and high rates of dropout have been seen in many studies [21,22,141,142]. 
Further insight into who the users and non-users are and whether use patterns can be used to 
inform the best type and best way to deliver Web-based interventions can be beneficial in 
targeting content to different groups of people with chronic illness [8,143,144]. The role of 
socio-demographic characteristics in relation to outcomes or issues of reach and adoption of 
eHealth interventions are only explored in a few studies [23]. This dissertation therefore 
explored user characteristics and use patterns of different components of a Web-based self-
management support system in study II. 
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2.4.1 User characteristics and use patterns of Web-based self-management 
support  
Several demographic factors are reported to influence use of Web-based self-management 
support systems. Higher age [145-147], female gender, higher education [148-150] and higher 
income [149] have all been associated with higher use. Some studies suggest that higher use is 
associated with younger age [149] or lower income [102], while other studies show no 
connection between user characteristics and system use [21,151,152]. In addition, how users’ 
health relates to usage is not clear. For some systems, higher levels of functional well-being 
[153] and not having a chronic condition [145] have been associated with higher use. In 
contrast, patients with a greater need for care were found to be more engaged in long-term use 
and in seeking out information in other studies [21,153]. These divergent findings indicate 
that further exploration of user characteristics in eHealth studies is needed. In this dissertation 
both demographic and disease-related variables are therefore included in study II and III to 
explore these relationships. 
Psychosocial factors are also described as having an impact on use. Lower levels of social 
support and symptoms of depression or negative mood have been associated with higher use 
[150,153,154]. In addition, prior Internet/computer experience has been identified as a factor 
linked with increased use and acceptance of eHealth interventions in some studies [146,155], 
but not others [152]. The limited evidence available on how psychosocial factors impacts use 
pattern motivated the aim in study II. 
Patients’ compliance with the intervention is not clearly described in many Web-based 
interventions [156]. The variability in usage is large [157], and some interventions are not 
used very often [158,159]. For example, website use has been described as relatively high 
initially and declining thereafter [71,152,160]. Studies often indicate the number of logins, but 
few examine the utilization of different program elements [161]. In a summary of 10 years’ 
experience with a Web-based support system called CHESS, Gustafson et al observed that 
different populations used CHESS in different ways [162]. For example, underserved 
populations used discussion groups less frequently, and used informational services and 
analyzing services more. In a study of a diabetes tool functionalities and self-management 
features were used by less than half of the participants even though user evaluation showed 
high satisfaction with the tool’s content, credibility and user-friendliness [63]. Baker et al. 
noted that participants now use Web-based support less often than they did before [163]. To 
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add to the sparse knowledge about usage of different program elements and about how user 
characteristics affect use of different components, we explored these aspects in study II 
through examining user characteristics associated with use of different components of 
WebChoice. 
It can be a challenge to compare results between studies, as the duration of the interventions 
varies widely. In the studies described in chapter 2.2, interventions are reported to last from 
four weeks [77] to 25 months [76]. In addition, recommended use varies widely. Some 
interventions are participant driven, where the participants chose the functions they want to 
use and how much they want to use them [7,76]. Other interventions are more prescriptive 
and offer a set of modules that the participants are meant to attend to or perform [56,77]. To 
ensure transparency in reporting eHealth interventions, descriptions of duration, 
recommended usage and how the intervention was actually used are strongly recommended 
[164], and this is therefore described in study III and III. 
Another known challenge in eHealth research is the large proportion of users who drop out 
before completion, or stop using the intervention [22]. Mean dropout rates of Web-based 
interventions are reported to be 21-23% [156,157]. Several studies report higher attrition rates 
in the intervention group than in the control group [6,57,62]. Dropout rates from RCTs of 
Web-based interventions are however low compared to dropout from open access websites 
[165]. Reasons given for dropout include deteriorating health, time constraints, technical or 
computer-access problems [57,165,166], family problems [57], nonparticipation in study 
activities [166], lack of motivation, burden of the program, lack of face-to-face contact, and 
perceived lack of treatment effectiveness or of improvement in condition [165]. Predictors 
reported for dropout are divorce [57], being single, low levels of computer skills [166] and 
being male [59]. To add to the knowledge on how user characteristics affect dropout, we also 
compared those who dropped out and those who stayed in study III. 
2.5 Contributors to effectiveness of Web-based self-management 
support 
2.5.1 Components and relations to effectiveness 
As described in chapter 2.2, a number of Web-based self-management interventions have 
demonstrated positive effect on patient outcomes [6-8,24,56,57,63,65,66,71,73,75-79,95-100]. 
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However, as mentioned before, these interventions often consist of several components, 
making it difficult to determine each component’s degree of contribution and benefit to 
patients [24,167]. Knowledge of the use and effects of single components on patient outcomes 
is important in identifying component candidates for inclusion in Web-based support systems 
[24,79,168], and in determining which components are effective as stand-alone services.  
In a study examining a Web-based support system for cancer patients, different features of the 
system were tested and compared [24]. Results suggested that the benefit of the system was 
connected to the information and support services. The complex services such as coaching 
and tailoring of content did not produce benefits beyond simple access to the Internet. Some 
of the same patterns could be seen in a study examining an intervention targeting 
fibromyalgia patients [158], where the presence of interactivity elements, such as a Web-
forum and chat room, failed to improve knowledge, empowerment or health outcome. 
A review of diabetes interventions found that the most effective systems were those that 
linked medical management and self-management [110]. Patient satisfaction was highest 
when the Web-based system gave them the ability to track blood glucose, receive electronic 
reminders, schedule physician visits, e-mail their health care team and interact with other 
diabetic patients. To add to the knowledge about effective components, in this dissertation the 
effect of one component (secure e-mail) was compared with the multi component support 
system, WebChoice. 
2.5.1.1 Secure e-mail 
There is growing interest among patients in using secure e-mail services [123,169,170], and 
several studies report positive effects of using secure e-mail alone in terms of assisting 
patients in managing illness, improving health outcomes, increasing satisfaction [171], 
reducing depression scores [172] and improving quality of care [173,174]. Patient access to 
secure e-mail is also associated with fewer visits to primary care offices [175-177] and 
telephone contacts [176,178]. In a review of interventions targeting chronically ill patients, 
communication with health care providers and/or website moderators was reported to be 
particularly useful for self-management support [5]. Similarly, in an earlier study of 
WebChoice, patients rated the nurse-administered secure e-mail service as the most valuable 
component [179], even though this service was managed by cancer nurses with no treatment 
responsibilities for the patients. Cornwall et al. also reported high levels of satisfaction with 
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nurse administered e-mail [137]. This suggests that secure e-mail can be important both as a 
stand-alone service and in multi-component Web-based support systems. However, little is 
known about the effect of stand-alone nurse-administered e-mail services and patient 
outcomes because previous studies have to a large extent focused on services between patients 
and physicians [134], and have not explored how they compare to more comprehensive Web-
based support systems where e-mail is one of several components. In addition, little is known 
about nurse-administered secure e-mail services integrated as part of routine care. Study III 
therefore tested the effects of nurse-administered secure e-mail services integrated in routine 
care, as well as the e-mail service with the additional features of WebChoice. 
2.5.2 Dose of use and relations to effectiveness 
A research topic within the eHealth field is the relationship between the amount of use and 
improvement in outcomes to explain the effectiveness of a program. An assumption behind 
this reasoning may be that more use will contribute to better health outcomes [180]. Little is 
known about the mechanisms or components of the interventions that have the greatest 
impact, however, and few formal evaluations consider user engagement or adherence to the 
Web-based interventions when addressing the overall impact on health outcomes [143]. 
There are many challenges in determining the role of intervention adherence on outcomes in 
eHealth interventions. A review of the impact of adherence on the effectiveness of eHealth 
interventions concluded that the number of logins, as a measure of adherence, correlated best 
with physical outcomes, while module completion correlated with psychological outcomes 
[141]. However, the studies included in this review examined very heterogeneous 
populations, interventions, length of follow-up and outcomes measured, and the authors 
therefore recommended further exploration of the relationship between adherence and 
outcomes. 
Several studies report no relation between Web-site use and outcomes [158,160,181]. Other 
studies, however, have detected positive associations. For example, higher use of Web-based 
diabetes interventions is associated with improved outcomes [61,105]. In a study of an 
eHealth intervention supporting palliative care among cancer patients, exploratory analysis of 
survival curves indicated no significant differences between the study groups [76]. However, 
a survival difference was detected in favor of the users, compared to the non users. Active 
users of an Internet peer support group for cancer reported a significant increase in fighting 
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spirit whereas non-users reported a decrease [182], and higher use of a support system for 
cancer patients was related to positive changes in patients’ psychosocial outcomes [180]. 
These findings of positive association between use and outcomes must however be interpreted 
with caution. Analysis of adherence and its relationship with outcomes often requires 
additional explorative analysis, which makes this evidence less robust. In addition, low usage 
or dropouts do not necessarily indicate failure, because dropouts may well be “e-attainers” 
who have accomplished what they needed from the eHealth intervention [183]. As such, there 
is no clear consensus on whether dose of use of Web-based self-management support and 
patient outcomes are connected. In study III, we therefore explored whether being a user or 
not was associated with differences in outcomes, seeking to further contribute to this 
knowledge. 
2.6 Theoretical framework 
2.61 The RE-AIM framework 
This dissertation addresses gaps identified in the literature related to uptake, use and 
effectiveness of eHealth interventions for self-management support and patient-provider 
communication. A framework widely used to plan, implement, evaluate and report health 
promotion and disease management interventions is the RE-AIM framework [16,184,185]. It 
was developed to improve the likelihood of translating health promotion interventions 
research into practice and focuses on factors facilitating intervention planning and evaluation, 
while balancing internal and external validity [16,26]. In addition, RE-AIM provides a set of 
outcomes that can aid in understanding the context of intervention development and testing, 
with a goal to speed up research-practice translation. RE-AIM is congruent with, and not 
opposed to, efficacy research, as it asks for transparency of procedures used, and details of 
inclusion and exclusion at the contextual levels of settings and  staff, as well as patients [186]. 
RE-AIM has earlier been adopted into eHealth evaluations [15,187], and was used as the 
theoretical framework in this dissertation. 
This dissertation mainly focuses on three of the RE-AIM dimensions; Maintenance, 
Implementation and Efficacy/Effectiveness. However, the Reach and Adoption dimensions are 
also addressed, especially in study III. 
The Reach dimension focuses on the characteristics of the participants. It highlights the 
importance of collecting information from both participants and non-participants to address 
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representativeness [16,188]. This can be an ethical challenge because non-participants have 
not consented to study inclusion [16]. In this dissertation, information on the Reach dimension 
is available in study III through description of individuals approached, eligible and consenting 
to participate in the study, and in study II where representativeness of participants is 
discussed. 
Efficacy or effectiveness is measured at the individual level and reflects the success of the 
intervention when implemented as guidelines prescribed under optimal conditions or in real-
world situations [16,188]. It is important to document both positive and possible negative or 
unintended consequences of the intervention. In this dissertation the effectiveness dimension 
is addressed in study III through outcome measures of symptom distress, anxiety, depression 
and self-efficacy. 
Adoption refers to the proportion and representativeness of the settings that adopt the 
intervention [16,188]. Different settings (e.g., hospitals) and agents (e.g., physicians, nurses) 
may vary based on resources, level of expertise and commitment to intervention programs. 
Understanding how adoption varies among settings and intervention agents is critical to the 
potential impact of an intervention. The framework also encourages examination of barriers to 
adoption when nonparticipating sites are assessed. In this dissertation, adoption is addressed 
by description of the number of hospitals that agreed to participate in study III, including 
reasons for not participating among those that declined. 
Implementation refers to the intervention agents' fidelity to the elements of an intervention's 
protocol [16,188]. This includes consistency of delivery as intended as well as the time and 
cost of the intervention. For the individual, implementation considers how the individual 
makes use of the intervention. This dimension is addressed in study II, focusing on user 
characteristics among users and non-users as well as user pattern. In addition, study III gives a 
broad description of user characteristics and of how WebChoice was used.  
Maintenance refers to the extent to which a program or policy becomes institutionalized or 
part of the routine organizational practices and policies [16,188]. At the setting level, the 
extent to which a program or policy is sustained, modified, or discontinued following initial 
trial or study period is addressed. In this dissertation the maintenance dimension is addressed 
in study I, where nurses’ experiences of the use of Choice in regular care were explored one 
year after implementation. 
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At the individual level, maintenance has been defined as the long-term effects of a program 
on outcomes after 6 or more months after the most recent intervention contact. This is not 
addressed in this dissertation. 
 
Table 2. RE-AIM framework dimensions, definitions and operationalization in the 
dissertation 
RE-AIM 
dimension 
 
Definition 
 
Variables measured in the thesis 
 
Reach 
 
The number and proportion of those 
invited and eligible who participate and 
their representativeness  
Study II: Representativeness of participants 
Study III: Number and percent of invited and 
eligible who participated and their 
representativeness 
Effectiveness/ 
Efficacy 
 
The amount of change in temporally 
appropriate outcomes and impact on 
quality of life or any adverse effects 
Study III: Effectiveness on symptom 
distress, anxiety, depression and self-
efficacy 
Adoption 
 
The number, percent, and 
representativeness of settings and staff 
invited who participate 
Study III: Hospital participation 
Implementation 
 
The extent to which a program or policy is 
delivered consistently, and the time and 
costs of the program 
Study I: Nurses experiences of  use 
Study II: User characteristics, use pattern 
Study III: User characteristics and use 
Maintenance The extent to which a program or policy is 
sustained, modified, or discontinued 
following initial trial or study period 
Study I: Nurses’ experiences of benefits and 
barriers to using Choice in regular care  
 
(Adapted from Bennett & Glasgow 2009) 
 
2.6.2 Additional theories and models 
In addition to the overall framework for the dissertation (RE-AIM framework), other theories 
and models informed the studies as well. Roger’s theory of diffusion of innovations states that 
users’ willingness to implement an innovation depends on five attributes of the innovation 
[189]. In study I, the findings were discussed in light of these attributes. In study II, the 
Comprehensive Model of Information Seeking (CMIS) was used to inspire disease-related, 
demographic, and psychosocial variables included in the analyses [190]. Rogers’ theory of 
diffusion of innovations and CMIS are described in more detail in paper I and II. 
2.7 Summary 
In summary, eHealth interventions for chronically ill patients hold promise in enhancing 
patient-provider communication and self-management, improving self-efficacy, knowledge, 
patient activation and health outcomes. However, there is a gap between eHealth interventions 
shown to be effective in clinical trials and interventions that are actually implemented and 
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maintained in regular practice. This indicates that barriers to benefiting from the possibilities 
of eHealth still exist. In order to improve the likelihood of translation of eHealth interventions 
into practice, there is a need to study several factors. This dissertation aspires to address 
aspects important for uptake, use and effectiveness of eHealth interventions. First, we focus 
on the challenge of maintenance of eHealth interventions in regular care by exploring nurses’ 
experience of using the electronic symptom assessment tool Choice, one year after 
implementation. Next, through exploring user characteristics and user patterns of the Web-
based self-management system WebChoice, we address the need to better understand how 
such systems are used and by whom. Finally, because eHealth interventions are often complex 
systems with multiple components, we compared a practice-integrated secure e-mail service 
and a multi-component self-management system (including the e-mail service) to disentangle 
effective components. The RE-AIM framework was used as a theoretical framework for this 
dissertation. 
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3. Methods 
This dissertation is based on scientific, practical and feasibility considerations. Originally, all 
data were to be obtained from study III. However, the initial collaborating hospital withdrew 
from the study just before patient recruitment was about to start. This delayed start-up of 
study III and resulted in change of plans. New hospitals were invited for collaboration; the 
process of setting up the necessary contracts and training health care providers in answering 
e-mails and in recruitment procedures, and eventually initiating and undertaking recruitment 
took a year longer than initially anticipated. A decision was therefore made to include data 
from two additional studies (study I and II) to make it possible to examine factors important 
for translation of eHealth interventions into practice. This allowed completion of the 
dissertation within the assigned time and with the available funding. Although this process 
was not as originally planned, the approach is scientifically meaningful because it provides 
data on all aspects intended for study in this dissertation. 
Consistent with RE-AIM, it is recommended that eHealth interventions should be evaluated as 
complex interventions and make use of more pragmatic designs rather than RCTs only [191-
193]. Pragmatic trials are designed to answer the question of whether a program works under 
usual conditions, compared to explanatory trials that answer the question of whether an 
intervention works under ideal conditions [194,195]. Complex interventions are described as 
interventions containing several interactive components [196]. Several characteristics of these 
interventions have to be considered, including the number of interacting components, the 
number and difficulty of behaviors required by those delivering or receiving the interventions, 
the number of groups or organizational levels targeted, the number and variability of 
outcomes and the degree of flexibility or targeting offered by the interventions [196]. Within 
health care, randomized controlled trials (RCTs) are seen as the “gold standard” to test 
interventions due to their unique ability to control for known or unknown confounding 
factors. RCTs are of great importance, as uncontrolled evaluations of complex interventions 
are reported to be twice as likely to yield positive results as controlled studies [197]. Although 
essential, this experimental design approach does not sufficiently account for and help to 
understand all contextual factors that play a major role in the success or failure of 
implementing complex interventions, such as eHealth interventions, into practice [25]. 
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Evaluation of eHealth interventions therefore often requires a multiple-method approach 
[191,193], which was used in this dissertation.  
This dissertation aims to move research on eHealth interventions for self-management and 
communication forward by addressing gaps identified in the literature related to uptake, use 
and effectiveness of eHealth interventions. These aspects are addressed using the RE-AIM 
framework and a multiple-method approach, including both qualitative and quantitative 
methods [198](p7). Qualitative methods, examining a deeper understanding of human 
experience are rooted in constructivism, while the quantitative approach comes from a 
positivistic tradition [199]. A qualitative approach was used to explore experiences of use of 
the Choice interventions in regular care (Study I). Quantitative methods were used to explore 
user characteristics and user patterns, and to test the effects of secure e-mail and WebChoice 
(Study II and III). This dissertation thus combines methods from different paradigms [198]. A 
combination of these methods within the same project might generate confusion about the 
ontological bases of the different approaches. However, several researchers within the social 
sciences are now articulating mixed-methods research as the third research paradigm [200]. 
Qualitative and quantitative methods could be viewed as complementary rather than 
conflicting [201], and a combination can thus offer a broader picture of a phenomenon 
[202,203] and be useful for better understanding the complexities of implementation 
processes [204]. The use of different materials and methods has been important in this 
dissertation because uptake, use and effectiveness of eHealth interventions involve several 
factors and stakeholders. 
All interventions included in this dissertation have either previously been tested in RCTs 
(Study I: [11]; Study II: [7]), or were tested in the present RCT (study III). In this dissertation, 
we move the research a little further; in addition to effects measured in the RCTs, we look at 
other aspects important to a deeper understanding of how, for whom and under which 
conditions such interventions could work. In the next sections, a description of the 
interventions studied is provided first. Next, an overview of the three studies included in the 
dissertation is provided, followed by methods for each study. Finally, ethical and security 
aspects are discussed. 
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3.1 Interventions studied 
This chapter presents an overview of the different interventions studied in this dissertation. 
The interventions build on each other and experiences regarding development, usefulness and 
usability are integrated into the development of each new intervention level.  
3.1.1 Choice 
Choice is the intervention t used by the nurses who participated in study I. It is an interactive 
tailored patient assessment and communication tool for cancer patients designed to (a) help 
patients report their experienced symptoms, problems, and priorities for care and (b) support 
clinicians in providing individually tailored symptom management support [11]. The 
development of Choice was based on a thorough literature review of symptoms, problems and 
symptom management in patients with cancer and on oncology expert focus groups as well as 
interviews with cancer patients [11]. 
Through Choice, patients report their symptoms and health problems along physical, 
functional, and psychosocial dimensions, record their degree of distress or affliction and 
prioritize their need for symptom care. The assessment in Choice is individually tailored to 
each patient based on his/her initial response, which allows patients to focus on aspects that 
are personally relevant, while skipping those that are not.  
 
Figure 1. The Choice tablet 
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When the assessment is completed, the system immediately creates a summary displaying 
patients’ selected symptoms and distress level, ranked by prioritized need for care (Figure 2). 
 
Figure 2. Screenshot showing the Choice summary sheet. 
The assessment summary is transferred to the hospital’s electronic system, and the patient 
receives a copy. The assessments themselves do not take up time for health care providers 
because patients complete these on their own prior to being seen by a clinician. The 
assessment summary can direct the clinician’s attention to the issues most important to the 
patient, and the results can assist care providers to better tailor symptom management and 
care for each patient, as well as to support and improve person-centered communication.  
When the nurses in study I used Choice, they handed out the touch-screen computer tablet to 
the patients and explained why and how to use it. The completed assessment summary was 
then used in patient-provider conversations in admission interviews, in follow-up 
conversations and in interdisciplinary meetings. 
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In clinical trials, Choice has been shown to significantly decrease cancer patients’ symptom 
distress over the course of their illness, reduce patients’ needs for care, increase disclosure of 
patients’ cues and concerns in communication with clinicians, and increase the number of 
symptoms and quality-of-life issues addressed in patient consultations [11,41,44,205]. The 
system has demonstrated satisfactory validity and reliability [206], and has received high 
ratings on usefulness by patients, nurses and physicians [207]. 
3.1.2 WebChoice 1.0 
WebChoice, the intervention used in study II, is a multi-component Web-based self-
management support system based on patient-centered principles. It is designed to assist 
cancer patients in self-management of their illness while at home [7,208]. It was developed in 
close cooperation with users and health care providers [209], and aims to enable patients to 
self-manage their illness and to facilitate patient-provider communication and partnership. 
WebChoice 1.0, used in study II, was designed for patients with breast or prostate cancer and 
contained the following components: 
1. A symptom assessment component based on the Choice intervention, in which patients can 
monitor their symptoms, problems, and priorities for support in physical, functional, and 
psychosocial dimensions. From a predefined list, patients can choose symptoms and problems 
they experience, and can rate the burden of these and what they need help with. Information 
from the symptom assessment can be used to monitor changes in the condition and determine 
when to alert health care providers, to prepare for a hospital/physician consultation, to 
contribute to improved patient-provider communication or to obtain immediate access to self-
management advice components as described below. 
2. An advice component that provide illness self-management support. Patients’ self-reported 
symptoms/problems trigger the display of appropriate self-management activities that patients 
can choose from in order to relieve their symptoms and problems. Each choice contains an 
explanation of what the activity is; how to perform it; potential risks, side effects, and 
contraindications; when to contact a physician; levels of evidence; references to the source of 
the evidence; and links to other reliable websites for related information. 
3. An information component in which patients have access to other reliable Web sources in 
Norwegian and English, such as information about tests, treatments, and potential side effects, 
lifestyle suggestions, and information about patients’ legal rights.  
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4. A communication component for sharing experiences with other patients or for obtaining 
help from oncology nurses. Patients can participate in an online forum group discussion that 
allow them to exchange messages anonymously with other patients, or use secure e-mail 
communication in which they can ask questions, share experiences, and get advice from 
oncology nurses. The nurses in study II were employed at the research center and were not 
involved in the direct care of the patients. They logged onto the communication component 
each weekday and they monitored and contributed to the discussion group when appropriate. 
5. A diary component where patients can keep personal notes. 
 
Figure 3. Screenshot of the WebChoice overview page. 
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Figure 4. Screenshot of results of an assessment, and the associated advice/interventions 
An RCT including 325 patients with breast cancer or prostate cancer, showed that WebChoice 
significantly reduced symptom distress [7]. During the study period, patients in the 
WebChoice group also showed significant within-group improvements in depression. This 
was not the case for the control group, which also experienced significant deterioration in 
self-efficacy and health-related quality of life during the study period [7]. Secondary analyses 
on data from this study were performed in Study II. 
3.1.3 WebChoice 2.0 
Following testing of the first version of WebChoice [7], feedback from patients through focus 
groups and questionnaires was used to update and refine the intervention [179]. In 
WebChoice 2.0, used in study III, targeting breast cancer patients, a blog component was 
added, the advice component could be accessed without finishing a symptom assessment first 
and the advice and link collection was refined and updated [210]. WebChoice 2.0 was also 
pilot-tested by cancer patients with different levels of computer experience in order to ensure 
user-friendliness. 
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Figure 5. Screenshot of the WebChoice 2.0 overview page 
One of the most appreciated components of the first version of WebChoice was the option of 
secure e-mail [179]. Health-related questions and worries are often the reason why patients 
schedule a physician appointment, suggesting that an e-mail service alone could, to some 
extent, help alleviate patients’ problems and concerns. Because an e-mail service is easier to 
develop and implement than more complex multi-component interventions, comparing such 
interventions is of interest. In order to further test and improve the component, the secure e-
mail service was redesigned in WebChoice 2.0 to also enable communication with a team of 
health care providers (e.g. nurse, physician and social worker) at the hospital of care. 
Messages from patients were received in an e-mail mailbox by a team of nurses. The nurse 
could either answer the e-mail directly, or forward the e-mail to the mailbox of physicians or 
social workers who could answer the patients directly or return comments to the nurse (see 
Figure 6). 
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Figure 6. Message flow between patients and health care providers in the secure e-mail 
service. 
 
As with other components of Choice and WebChoice the e-mail service was developed in 
close cooperation with patients and health care providers who described the needs and 
necessary functions and also tested prototypes and the final version of the e-mail service 
[211]. 
In this dissertation, “WebChoice” refers to WebChoice version 1.0 in study II and WebChoice 
version 2.0 in study III. 
3.2 Overview of the studies in the thesis 
The main objective of this dissertation was to address important challenges identified in the 
literature related to uptake, use and effectiveness of eHealth interventions into practice from 
different perspectives: 1) To explore nurses’ experiences of benefits of and barriers to 
maintaining use of Choice in cancer care, one year after its implementation (study I); 2) To 
describe user characteristics associated with the use of different components of WebChoice 
(study II); and 3) To test and compare the effects of (a) a secure e-mail service, (b) the e-mail 
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service with additional features of WebChoice, and (c) usual care on patient outcomes after 6 
month of access (study III). 
To address these objectives, multiple methods and methodologies were used. Below is a 
summary of design, participants, methods for data collection and analysis in each of the three 
studies. 
 
Table 3. Study overview 
Study Study I Study II Study III 
Design Qualitative 
Retrospective descriptive 
Quantitative 
Exploratory secondary 
analysis 
Quantitative 
Effect study, RCT 
Group 1: WebChoice 
Group 2: Secure e-mail 
Group 3: Usual care 
Participants N=20 
Nurses  
 
N=162 
Intervention group from a 
previous RCT 
Breast and prostate cancer 
patients 
N=167 
Breast cancer patients 
Data 
collection 
Interviews in groups  Existing data from self-
reported instruments and 
system use 
Self-reported instruments and 
system use 
Data 
analysis 
Qualitative content analysis  
 
Descriptive statistics 
Logistic regression 
Latent class analysis 
Descriptive statistics 
Linear mixed model 
 
3.3 Study I 
3.3.1 Design  
In this qualitative study, the aim was to explore nurses’ experiences of benefits of and 
barriers to maintaining use of Choice in cancer care, one year after its implementation. Focus 
groups as described by Brink & Wood (1998)[212] were used to explore their experiences. 
Focus group discussions have the qualities of interviews as well as discussions [213] and also 
benefit from group dynamics [214] through stimulating participants to interact and exchange 
comments and feedback, with the ultimate goal to elicit as wide a range of experiences as 
possible. 
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3.3.2 Participants 
The focus groups included nurses who had been part of the implementation process and who 
had used Choice in regular practice for one year. They were recruited from three inpatient and 
one outpatient cancer ward at two teaching hospitals in Norway. Head nurses identified 
potential participants, and nurses received information leaflets regarding participation. A total 
of 20 nurses agreed to participate, two males and 18 females, ranging from 23 to 55 years old 
(mean 34), with a range of 1 to 25 years (mean 5.9) of nursing experience. Of the participants, 
eight nurses had a clinical specialist education, such as oncology, mental health, intensive 
care or a master of nursing science.  
3.3.3 Procedure for data collection 
To address the maintenance dimension of the RE-AIM framework, an interview guide was 
developed by the research team to foster consistency in the questions asked across groups 
[214]. The opening question concerned the participants and their initial thoughts about being 
in the study. After a brief introduction to the area of interest, participants were asked about 
their experiences using Choice in their daily work. Thereafter key questions were posed 
concerning Choice’s ability to elicit the patient’s symptoms, problems and priorities for help, 
possibilities and challenges and perceived barriers to using Choice. The interview guide ended 
with an invitation for participants to comment on the assistant moderator’s oral summary of 
the discussion (see appendix). The interview guide was first tested in a pilot focus group 
consisting of experienced nurses. No changes were made in the interview guide and the 
results from the pilot were included in the study.  
Four focus group discussions were conducted in hospital meeting rooms with 4-6 respondents 
in each group. To circumvent the risk that experienced nurses would dominate the discussion 
in the groups [215], the respondents were divided into two groups of experienced nurses (two 
or more years at the unit) and two groups of less experienced nurses (less than two years at 
the unit). 
The focus group discussions lasted between 56 minutes and 123 minutes and were audio-
taped and transcribed verbatim by the PhD candidate. During all the discussions the PhD 
candidate and a colleague (both experienced nurses) were present and alternated between 
being moderator and assistant moderator in the different focus group discussions. The 
moderator asked questions to encourage participants to elaborate when their statements were 
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vague. The co-moderator took the role of an observer and recorded field notes during the 
focus groups. Immediately following the focus groups, the moderator and co-moderator met 
to discuss and record impressions from the discussions in an observation log. 
3.3.4 Analyses 
The analytical process of study I was guided by qualitative content analysis, a method of 
systematically analyzing written or verbal communication [216], as described by Graneheim 
and Lundman [217]. As little is known about how communication tools such as Choice are 
received in an organization, an inductive approach was chosen. This means that themes and 
subthemes were derived from data and not simply structured on the basis of a theory or 
previous knowledge [218]. The analysis examines both the manifest (i.e. the visible, obvious 
components) and the latent or underlying content meaning in the text [217]. An approach 
based on inductive data moves from the specific to the general in several steps, which will be 
further described below (table 4). The analysis was performed in an interactive process by the 
PhD candidate and the last author (ME). First, to obtain a “sense of the whole”, the interviews 
were thoroughly read in order to obtain a comprehensive understanding of the nurses’ 
experiences of using Choice. Second, meaning units, i.e. sentences and paragraphs containing 
aspects related to the same central meaning through content or context [217], were extracted 
from the text. The meaning units were condensed and summarized and where possible 
described in terms of the underlying meaning, preserving the core content. The condensed 
meaning units were compared for similarities and differences and abstracted into sub-themes. 
By continuously examining parts, as well as the entire text, three main themes and nine sub-
themes describing the nurses’ experiences were abstracted (see Table 2, Paper I). To ensure 
trustworthiness, the sub-themes and themes were discussed between the first and last author 
as well as within the research group until agreement was reached. To increase the 
transparency of the interpretation, themes and subthemes were illustrated with quotations in 
paper I. 
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Table 4. The analytic process of focus group interviews illustrated by extracts of meaning 
units, condensed meaning units, sub-themes and theme 
Meaning units Condensed 
meaning units 
Sub-themes Themes 
“I’m mentally prepared for the 
conversation, ... I have time to think 
things through, both what answers I 
can provide, what feedback and 
support I can offer” 
 
“It’s probably a way for them as 
patients to become more aware, 
writing thoughts down and being able 
to organize and better sort things 
through” 
 
“The patient is well prepared. He 
knows that he has already checked 
something off, rather than suddenly 
being asked about it. Or if they come to 
us, they are more prepared when they 
know they have already checked 
something off” 
Having time to think 
through, prepares the 
nurse for 
communication 
 
 
Becoming aware of, 
and structuring 
thoughts 
 
 
Knowing what 
problems they have 
checked in Choice 
prepares the patients 
for communication 
 
 
 
 
 
 
Prepares both 
patient and nurse 
for 
communication 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Facilitator for 
shared 
understanding and 
engagement in 
patients’ own care 
“It’s actually easier to prepare 
treatment plans through the use of 
Choice. Problems and issues are more 
evident there, the needs of the patient 
more clear, and rather than guessing 
it’s easier to determine what needs to 
be done pointing to Choice and Choice 
results” 
 
“When you use Choice you ask ‘what 
do you think if this could help like this 
or like that?’ That way he participates 
in the decision making about his own 
treatment, we create a plan based on 
our discussions, and he has indirectly 
participated in making his own 
treatment plan” 
 
Information revealed in 
Choice was used as a 
basis for care planning 
 
 
The patient indirectly 
participates in own care 
planning through use 
and communication 
about Choice results 
 
 
 
 
 
 
 
 
Shared 
engagement in 
care planning 
“With the quiet ones, we find out about 
problems we didn’t think they had…” 
 
“And I think there’s something in 
treating people equally but differently. 
That the tool allows everyone to speak 
on an equal footing” 
 
“At the same time, it will be up to the 
patients how much they want to reveal 
about their thoughts, concerns, and 
struggles” 
Healthcare 
professionals get 
insight into the worries 
of more quiet patients 
 
Each patient has an 
equal opportunity to be 
heard 
 
The patients decide 
how much they want to 
share 
 
 
 
 
Gives the patients 
a voice 
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3.4 Study II 
3.4.1 Design 
In this study the aim was to describe user characteristics and user patterns associated with 
the use of different components of WebChoice. To address this aim, a quantitative exploratory 
secondary analysis of the RCT in which WebChoice was tested among 325 women with 
breast cancer and men with prostate cancer [7] was conducted. Secondary analyses involve 
analyses of data collected for another study, to test new hypotheses or to explore new 
relationships [219, p.236]. 
Two research questions guided the study: 1) What demographic-related, illness-related, and 
psychosocial variables are associated with the use of WebChoice? 2) Among WebChoice 
users, what are the associations among levels of patients’ symptom distress, social support, 
depression, self-efficacy, health-related quality of life, and their use of different WebChoice 
components? 
3.4.2 Participants 
Participants in study II were the 162 respondents from the intervention group (access to 
WebChoice) in the above-mentioned RCT. In the RCT, patients had been recruited through 
advertisements in newspapers, in the Norwegian Cancer Society’s magazine and on their 
website, and through pamphlets mailed to potential participants through the Norwegian 
Cancer Registry. Inclusion criteria were; undergoing active treatment for breast or prostate 
cancer, above 18 years of age, able to read/speak Norwegian and having access to Internet at 
home. 
3.4.3 Procedure for data collection 
All respondents had completed baseline questionnaires before randomization. Baseline data 
were retrieved from existing files from the RCT. Data on system use, during one year of 
access to WebChoice, were extracted from user logs on the server. Those who had logged on 
less than twice were categorized as non-users; those who had logged on twice or more were 
categorized as users. We specified a minimum of two logins because patients who only 
logged on once might only have read the welcome message and never actually used the 
system. Information was collected in the RCT regarding how many times the users logged on, 
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how much time they spent on the site and on each component and which components of 
WebChoice they accessed or used actively (e.g. sent e-messages or postings in the forum). 
3.4.4 Self-report assessments 
In the RCT, participants had completed self-report questionnaires related to demographic and 
disease-related characteristics as well as psychosocial variables. 
Demographic variables (age, gender, marital status, level of education and household income) 
and diagnosis-related variables (diagnosis of breast cancer or prostate cancer, time since the 
diagnosis, recurrence/metastasis, type of treatment and other illnesses) were recorded with a 
study–specific questionnaire. 
Symptom distress was measured using the 32-item Memorial Symptom Assessment Scale – 
Short Form (MSAS-SF) [220]. Symptom distress was measured with 5-point Likert scales, 
where respondents rated the degree from “not at all” (0) to “very much” (4). Higher scores 
indicated greater symptom distress. Cronbach’s α for our sample at baseline was 0.92. 
Social support was measured with the 20-item Medical Outcomes Study Social Support 
Survey (MOS-SS), including five sub-scales addressing emotional, instrumental, tangible and 
affectionate support and positive social interaction [221]. Responses on 5-point Likert scales 
ranged from “none of the time” to “all of the time”. Higher scores indicated more social 
support. Cronbach’s α for our sample at baseline was 0.96. 
Depression was measured with the 20-item Center for Epidemiological Studies Depression 
Scale (CES-D) [222] with responses on 5-point Likert scales ranging from “rarely or none of 
the time” to “most or all of the time”. Higher scores indicated greater depression. Cronbach’s 
α for our sample at baseline was 0.88. 
Self-efficacy was measured with the 33-item Cancer Behavior Inventory (CBI) version 2.0 
[223], measuring coping self-efficacy with cancer-related stress on seven dimensions: 
maintenance of activity and independence; seeking and understanding medical information; 
stress management; coping with treatment-related side effects; accepting cancer and 
maintaining a positive attitude; affective regulation; and seeking support. Responses on 9-
point Likert scales ranged from “not at all confident” to “totally confident”. Higher scores 
indicated greater self-efficacy. Cronbach’s α for our sample at baseline was 0.95. 
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Health-related quality of life (HRQoL) was measured using the 15-item 15D preference-based 
single index [224]. From five ordinal levels on each dimension, respondents chose the one 
that best described their present health status. Higher scores indicated greater HRQoL. 
Cronbach’s α for our sample at baseline was 0.77. 
Computer experience was assessed with a simple question about patients’ experience with 
computer use, ranging from 1 – no computer experience at all; to 5 – a lot of computer 
experience. 
3.4.5 Analyses 
In this study, descriptive statistics, logistic regression and Latent Class Analysis (LCA) were 
used. Data were presented as medians and ranges for continuous variables and as proportions 
and percentages for categorical data. Associations between categorical variables among users 
and non-users were analyzed using the χ2-test for pairs of categorical variables; the Mann-
Whitney test was used for continuous data with skewed distributions. A multiple logistic 
regression model was fitted to compare users and non-users on demographic, disease-related 
and psychosocial variables. Variables with a P-value < 0.2 in the univariate logistic regression 
analyses were included in the multiple regression model. 
To prepare the data for LCA, total scores on symptom distress, social support depression, self-
efficacy, HRQoL and the data on system use of the different WebChoice components were 
divided into tertiles based on the scores for patients with breast or prostate cancer combined, 
using the whole sample of patients with access to WebChoice (Paper II, Multimedia 
Appendix 1). 
3.4.5.1 Latent Class Analysis (LCA) 
To identify characteristics associated with use of different components of WebChoice among 
users, we used LCA, which is a statistical method designed to identify whether there are 
underlying types or subgroups of individuals that share specific characteristics [225]. LCA is 
a pattern recognition technique based on the statistical concept of likelihood and thus based 
on the same principle as factor analysis. The main difference is that cases are not absolutely 
assigned to classes, but have a probability of membership for each class. The results are 
presented with estimated probabilities and formal statistical tests can be performed to evaluate 
different models (see paper II). The main goal for this LCA was to identify how a set of user-
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related variables could be associated with different system use. Utilizing LCA enabled us not 
only to identify these associations but also to quantify their direction and strength. Due to a 
limited sample size, we fitted LCA models with at most three classes and at most four 
explanatory variables to avoid overfitting and multicollinearity. 
We expected different user patterns for breast and prostate cancer patients because these 
patient groups differed with regard to gender, age, treatment and presence of other illnesses. 
Therefore, all LCA models were stratified by type of diagnosis and adjusted for age at 
inclusion. 
To select variables for inclusion in the final LCA models we first fitted models where one 
psychosocial variable at a time was tested together with sets of three and three user variables. 
The psychosocial variables that revealed clear patterns of use were kept and integrated in the 
final LCA models, where a cluster of psychosocial variables was tested with single user 
variables. 
The descriptive statistics and logistic regression were carried out using SPSS version 16.0 
(SPSS Inc, Chicago, IL, USA). LCA was performed with SAS version 9.3, using the PROC 
LCA procedure for LCA [226]. P-values <.05 were considered statistically significant and all 
tests were two-sided. 
3.5 Study III 
3.5.1 Design  
The aim of this study was to test and compare the effects of (1) a secure e-mail service, (2) 
the multi-component WebChoice intervention (including the e-mail service), and (3) usual 
care (control group) on symptom distress, anxiety, depression (primary outcomes) and self-
efficacy (secondary outcome) after 6 month of follow up. We hypothesized that; the 
WebChoice group compared with the usual care group, would have better outcomes than the 
secure e-mail group compared with the usual care group. We also hypothesized that both 
groups would have better primary and secondary outcomes than the usual care group. 
A RCT design with three groups was used to test these effects, as the RCT design is 
considered the gold standard for efficacy/effect research [227]. Although it provides no 
guarantee of getting equal groups, this design is the most acceptable to ensure that variables 
assumed to impact outcome variables (confounding factors) are randomly distributed in the 
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groups, thus making the groups comparable [212, p.29]. Additional explorative analyses were 
also performed to detect whether the outcomes were associated with the actual use of the 
interventions. 
3.5.2 Study sites 
Initially, a large University Hospital in Oslo agreed to participate in the study by providing 
access to recruitment of patients, and health care providers to answer e-mail from patients. 
Unfortunately, when the study was ready for start-up, the hospital withdrew from participation. 
The reasons given were reorganization of the hospital and lack of resources to answer e-mail 
from patients. As all preparations had been made with this hospital, with permissions, etc., we 
had to start all over again, which delayed the study by one year. 
Ten hospitals from all over Norway were then contacted via e-mail and invited to participate. 
Five declined due to ongoing studies or lack of resources to participate. Five sites were 
interested and were given an in-person presentation of the study and the activities it would 
entail for them. Two of these hospitals concluded that they were not able to participate. Again, 
lack of resources was given as the reason. 
Three hospitals agreed to participate. Study participants were recruited from one university 
hospital and two regional hospitals, at breast diagnostic centers or ambulatory chemotherapy, 
radiation and surgical units. The hospitals/units did not receive any incentives for participating 
in the study. For more details, see paper III.  
3.5.3 Participants and sample 
A statistical power of 80% to detect an effect size of 0.25 at the 5% significance level and a 
sample size of 369 respondents were originally calculated. This sample accounted for an 
expected 30% dropout rate during the study period and a 70% utilization rate of the 
intervention, similar to observations in the previous RCT of WebChoice [7]. Due to the 
withdrawal of the initial collaborating study site and challenges with slower recruitment than 
anticipated at the three hospitals where the study took place, we had to stop inclusion after 200 
consenting participants, before the calculated sample was obtained. Study III reports on 167 
patients for whom 6-month follow-up data were available at the time this manuscript was 
written. These participants were recruited between May 2010 and September 2012. 
39 
 
Inclusion criteria were recent diagnosis of breast cancer treated with surgery, or under 
treatment with radiation, chemotherapy, hormone therapy, or combinations of those 
(maximum 12 months after surgery), age over 18 years, able to write/read and speak 
Norwegian, having access to the Internet at home and with a public key solution for secure 
system access (PKI). 
3.5.4 Study procedures 
3.5.4.1 Pilot 
A pilot study of the experimental intervention, data collection and associated procedures was 
conducted with 15 breast cancer patients, five from each site. The interventions and 
instruments for data collection worked well. Necessary adjustments in relation to recruitment 
procedures and information to patients were made before the RCT began. 
3.5.4.2 Recruitment 
Eligible patients scheduled for surgery or coming for check-ups after surgery or treatment were 
identified by the study nurses at the hospitals. Upon patients’ arrival at the clinic, the study 
nurses met the patients, provided brief information about the study and asked if they were 
interested in participating. If the patients agreed, the nurse informed them about the study’s 
purpose and procedures, and asked for written informed consent. Consenting patients 
completed baseline questionnaires before randomization. 
3.5.4.3 Randomization 
After completion of baseline questionnaires, patients were randomized according to a 
predefined automated computerized block randomization, with a block size of 42 stratified by 
site. To avoid selection bias, the randomization was performed by an external research office, 
independent of both the researchers and clinicians in the study. The block size was not known 
to the researchers before analysis of the data. Due to the content of the interventions, patients 
could not be blinded to which arm they were randomized. 
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Figure 7. Flow of participants throughout the trial. 
3.5.4.4 Interventions 
Patient randomized to the usual care group were followed up as usual at the hospitals where 
they were treated. Patients who were randomized into the secure e-mail or WebChoice groups 
were informed and instructed in the use of the system. They received a printed user manual 
with instructions for use, how to log on to the system, contact address and phone number for 
help if needed. The only in-person information given was instruction on how to access the site 
and how to connect with the study support service if questions occurred. The study nurses 
showed them where in the user manual they could find information about how to access the 
site and how to connect with the study support service if needed. In addition, the participants 
were informed that they could use the e-mail or any component of WebChoice as much or as 
little as they liked, and that using the system was entirely voluntary. The e-mail component 
was the same for both intervention groups. 
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After being informed about the group assignment, the patients were given access to the 
interventions the same day. They received an automatic welcome message when the system 
was ready to use. There was an option to be notified by SMS or regular e-mail when new 
messages appeared in the system. Most participants wanted this notification.  
3.5.4.5 Care providers 
Care providers (n=20; 11 nurses, 6 physicians and 3 social workers) who answered questions 
from patients consisted of a dedicated group of expert nurses and physicians in breast cancer 
care, and social workers at the hospital where the patients were treated. They were thoroughly 
trained in administering the secure e-mail service, technically as well as in codes of conduct 
for online communication with patients and there was a clear schedule for who was 
responsible for answering patients’ messages. The nurses were first-line responders, and 
received all messages first. If necessary, they could forward the message to other care 
providers. If considered important, information from the e-mails could be copied into the 
medical record and made available for other health care providers. When new questions 
arrived in the system, the recipient was notified through the hospital’s e-mail system or by 
SMS. The same providers answered e-messages from both the secure e-mail and WebChoice 
groups using the same interface. However, they were not entirely blinded to the intervention 
group assignment because patients sometimes disclosed their group identification in the 
messages. The health care providers had no access to details about how patients used other 
components of WebChoice. They did not receive any reimbursement or additional dedicated 
time for answering secure e-messages from the participants. 
3.5.5 Procedure for data collection 
All outcomes were measured at baseline and at 2, 4 and 6 months post baseline, through self-
report questionnaires sent to participants by postal mail from an external research office. If no 
response was received within two weeks, a letter with a reminder was sent once, and 
participants were informed that they could withdraw from the study at any time. The 
researchers and the clinicians who answered the secure e-mail had no influence on these 
reminders. Data on system use were extracted from the user logs on the server. As in study II, 
those who had logged on less than twice were categorized as non-users; those who had logged 
on twice or more were categorized as users. Information was collected on how many times the 
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users had logged on as well as the components of WebChoice that were accessed or used 
actively (e.g. sent e-messages or postings on the forum). 
The primary outcomes were symptom distress, anxiety and depression. The secondary 
outcome was self-efficacy. 
3.5.6 Self-report assessments 
Demographic variable/characteristics (age, marital status, level of education, employment 
status, household income and the use of Internet services) were recorded with a study–specific 
self-report questionnaire. 
The time of diagnosis and stage of disease were obtained from the medical record. Based on 
the patients’ tumor (T), node (N), and metastasis (M) classification at the time of diagnosis, 
the stage of disease was classified into 5 stages (0 = ductal carcinoma in situ, to 4 = advanced-
stage disease) using the TNM Classification of Malignant Tumours of the Union for 
International Cancer Control guidelines [228]. 
Comorbidity was measured with the Self-Administered Comorbidity Questionnaire (SCQ-19), 
which evaluates the number of, treatments for, and functional impact of health problems. It 
includes 16 common comorbidities and 3 optional conditions [229]. The total SCQ-19 score 
can range from 0 to 57 when the 3 optional items are used. It is a clinical scale, with 
established validity and reliability [229], for the assessment of comorbidities in patients with 
chronic medical conditions. A higher total score indicates a more severe comorbidity profile. 
Symptom distress was measured in this study by using the full version of the 32-item 
Memorial Symptom Assessment Scale (MSAS) [220], which lists physical and psychological 
symptoms that occur due to cancer or its treatment. For each symptom, patients were asked to 
indicate whether they had had the symptom during the previous week. If they had experienced 
the symptom, they were asked to rate its frequency, severity, and associated distress. 
Symptom frequency and severity were rated using a 4-point Likert scale. Symptom distress 
was rated using a 5-point Likert scale. The validity and reliability of the MSAS are well 
established [220], and MSAS has previously been used in breast cancer populations [230]. 
Higher scores indicate greater symptom distress. Cronbach’s alpha coefficient for our sample 
at baseline was .85. 
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Anxiety and depression were measured with the Hospital Anxiety and Depression Scale 
(HADS) [231], a 14-item, self-report measure of psychological distress. The HADS is divided 
into 2 subscales: anxiety (HADS-A) (7 items) and depression (HADS-D) (7 items). 
Respondents are asked to indicate which of 4 response options (rated from 0 to 3; score range, 
0-42) comes closest to describing how they have been feeling in the previous week for each 
item. Scores from 0-7 on the subscales are regarded as being in the normal range; a score of 
11 or higher indicates probable presence of a mood disorder, and a score of 8 to 10 is 
suggestive of the presence of anxiety or depression [232]. The scale has been found to 
perform well in assessing the symptom severity of anxiety disorders and depression in 
hospital settings, in primary health care and in the general population [233]. Cronbach’s alpha 
coefficient is reported to vary from .68 to .93 for HADS-A, and for HADS-D from .67 to .90 
[233]. In our sample, Cronbach’s alpha coefficient at baseline was .83 for HADS-A and .76 
for HADS-D. 
Self-efficacy was measured with the 33-item Cancer Behavior Inventory (CBI) version 2.0 
[223]. See further description of the instrument in the method section of study II. Cronbach’s 
alpha coefficient for our sample at baseline was 0.96. 
3.5.7 Support and surveillance 
The project administrator (the PhD candidate) and IT support staff were available by phone 
during weekdays to answer questions from both patients and health care providers regarding 
participation in the study as well as how to perform different tasks in the interventions they 
were assigned to, and to respond to technical questions. All participants were informed that 
WebChoice/secure e-mail service could not be used for urgent matters requiring immediate 
medical attention. To provide help in using the different components, a short explanation was 
available when participants pressed the “read more” button on each component.  
For the discussion forum, guidelines for use were created to ensure appropriate conduct. A 
nurse employed by our research center monitored new postings to ensure proper use and 
adherence to the guidelines. The project administrator monitored e-mail communication to 
ensure that requests sent by patients were responded to within the promised two-workday 
window. 
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3.5.8 Analyses 
Differences between users and non-users were analyzed using the χ2-test for pairs of 
categorical variables and the Mann-Whitney-Wilcoxon test was used for continuous data with 
skewed distributions. 
For analysis of between-group differences in symptom distress, anxiety and depression 
(primary outcomes) and self-efficacy (secondary outcome), linear mixed models (LMM) for 
repeated measures were fitted. A diagonal covariance structure was used to model 
dependencies among measurements on the same individual at different time points. Models 
for each outcome consisted of 3 effects: measurement occasion (time), interventions 
(WebChoice, IPPC, usual care) and the interaction of time and intervention. All measured 
time points of the outcome variables were considered and the LMM approach therefore 
adjusts for baseline differences. To test whether potential confounders impacted the results, 
LMM adjusted for variables such as site, age, marital status, education, time since diagnosis, 
stage of disease and comorbidity were fitted. Compared to the unadjusted models, these 
adjusted models revealed even larger differences in favor of the intervention groups compared 
to the usual care group. Taking the limited sample size into account and aiming to avoid over-
fitting, only the results from the unadjusted models are presented. As no statistically 
significant differences were observed between the study groups on demographic and disease-
related factors at baseline, these models were not adjusted further for the possible 
confounders. This approach might underestimate the true differences between the groups, but 
was chosen based on the limited sample size. Analyses of primary and secondary outcomes 
were conducted on an intention-to-treat basis, including all participants in each group, 
independently of whether they were users or non-users of the interventions. 
The model parameters were estimated using the classical maximum likelihood approach. No 
imputation of missing data was necessary or performed, as the LMM uses all data available to 
estimate the covariance matrix and model the dependencies. The results are presented as p-
values for the overall effect of the variables when the baseline score and all time points are 
included. Moreover, overall mean differences are presented, i.e., the difference between 
groups adjusted for baseline scores and taking all time points into consideration. Reporting of 
overall mean differences was chosen because we were interested in differences between the 
groups over the entire six-month period. 
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In addition, explorative sub-analyses were performed to detect whether the outcomes were 
associated with the actual use of the interventions. LMM for repeated measures were fitted for 
each outcome with three factors: measurement occasion (time), intervention (user/non- user of 
WebChoice and secure e-mail) and the interaction between time and intervention. In addition, 
age was added as a covariate because age is known to be associated with use of Web-based 
self-management support systems [145-147,149]. 
Analyses were carried out using SPSS version 18.0 (SPSS Inc, Chicago, IL, USA). P-values 
<.05 were considered statistically significant and all tests were two-sided. 
3.6 Ethical aspects 
All three studies in this dissertation were planned and performed in compliance with the 
principles outlined in the Declaration of Helsinki [234]. They were approved by the Regional 
Committee for Medical and Health Research Ethics in Norway (Study II: 2.2205.1593; study 
III: 6.2009.1098), the Privacy Protection Committee at the hospital (Personvernombudet) 
(Study I: 07/8617; study III: 2010/543), and the Data Security Inspectorate of Norway (Study 
II: 05/01308-2). Study II and III were registered at ClinicalTrials.gov (NCT00710658, 
NCT00971009). 
Written informed consent was obtained from both patients and health care providers. They 
were informed that participating was entirely voluntary. The patients who participated in 
study II and study III were informed that they could use the assigned intervention 
(WebChoice/secure e-mail) as much or little as they wanted. Participants in study I and III 
received no reimbursement for participation. However, in the previous RCT, patients in study 
II had received a lottery ticket worth 20 Norwegian kroner upon completion of their last 
questionnaires. 
In the focus groups with nurses as participants, the nurses were informed that data would be 
coded and treated confidential and no statements could be traced back to the identity of the 
participants. Analyses were performed on the transcribed material only (i.e., not the tapes or 
audiotapes) and the transcribed materials were stored on a secure server at the hospital. 
Participants in study III were asked to complete questionnaires four times over a six-month 
period. Because the participants were included within one year after diagnosis, and thus were 
dealing with symptoms from the disease as well as the ongoing treatment, completing all forms 
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could be experienced as burdensome for some. However, if completed questionnaires were not 
received only one reminder was sent to the participants. 
3.7 Security 
Strong security levels were implemented to protect the information sent by the patients 
through the WebChoice interventions. All data were submitted to a secure server at the Oslo 
University Hospital using an encrypted connection. Patients and health care providers were 
authenticated using a smart-card based public key (BuyPass) in WebChoice 1.0 and hence had 
to learn a new procedure in order to log on to the system. In the revised version of 
WebChoice, WebChoice 2.0, a public key solution that is currently used by Norwegian banks 
as a security platform (BankID) was used for authentication. Using BankID, the log-on 
procedure is the same for the users whether they log for online bank services or for the secure 
WebChoice/e-mail service. All procedures complied with the Norwegian Data Protection 
Authority. 
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4. Results 
A summary of the dissertation results appears below. A more detailed description of the 
results can be found in each paper separately. 
4.1 Study I 
Nurses’ Experiences of Using an Interactive Tailored Patients Assessment Tool One Year 
Past Implementation 
The objective of this study was to explore nurses’ experiences of the benefits and the barriers 
to maintaining use of Choice in routine cancer care one year after implementation. Transcripts 
from the focus group discussions were abstracted into three main themes showing that Choice 
facilitated shared understanding and engagement, enhanced the patient’s strengths and 
imposed new challenges and ethical demands on the health care professionals. The three 
themes and subthemes are presented in brief below:  
Theme 1:“Choice as facilitator for shared understanding and engagement in own care”. 
Choice was considered a facilitator for communication. Nurses reported that Choice enabled 
patients to express and share their symptoms and priorities for care with the nurses, making 
both patients and nurses better prepared to communicate and plan care. The subthemes 
identified under theme 1 were: “Preparing both patient and nurse for communication”, 
”Shared engagement in care planning”, and “Giving the patients a voice”. 
Theme 2: “Enhancing the patient’s strength”. When using Choice, patients were able to 
process and think through many of their problems and the nurses perceived that some healing 
took place as a “side effect” during the process. The subthemes identified were “Release of 
internal strengths” and “Confirming “‘normalcy’”. 
Theme 3: The third theme, “New challenges for the nurse”, dealt with challenges that 
emerged through use of Choice in routine care. These challenges were divided into four sub-
themes: “Organizational challenges” including, time to perform the new task and the need 
for routine changes to better fit Choice into the workflow. “Interactions with technology” 
involving lack of compatibility between different computerized systems and impressions of 
use of technology. The sub-theme “A need for communication skills training” raised the issue 
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of new skills needed to make full use of Choice in communication with patients. Finally, 
“New ethical challenges”, included topics such as results from Choice being overwhelming 
for the nurse, making them feel bad when unable to discuss all topics from the assessment, or 
feeling as though they were violating the privacy of patients. For details, see paper I. 
4.2 Study II 
How User Characteristics Affect Use Patterns in Web-Based Illness Management Support 
for Patients with Breast and Prostate Cancer 
The objective of this study was to explore, in a secondary analysis, user characteristics and 
user patterns associated with the use of different system components of WebChoice. About 
two thirds (103/162) logged on to WebChoice more than once, and were defined as users. The 
users had visited WebChoice on average 12 times (median) during the year (range 2-829). Of 
the patients who had access to WebChoice, 38% (62/162) had sent e-messages to care 
providers (Table 5, paper 2). Patients with high level of computer experience were almost 
four times more likely to use WebChoice  than those with no or little experience, and having 
no additional illnesses besides cancer increased the probability of being a user by a factor of 
two (OR=.3.77, CI 1.20-11.91; OR=2.10, CI 1.02-4.34, respectively). Latent class analyses 
showed that both men with prostate cancer and women with breast cancer who had low scores 
on social support, accompanied by high levels of symptom distress and high levels of 
depression, were more likely to use the e-mail component. For men with prostate cancer, 
these variables were also associated with high use of the self-management advice component. 
Significant differences between men with prostate cancer and women with breast cancer were 
found in analysis of associations between WebChoice use and user characteristics. High use 
of all WebChoice components was associated with low levels of social support among women 
with breast cancer but not among men with prostate cancer. High use of e-mail, advice, and 
the discussion forum was associated with high levels of depression among women with breast 
cancer, but not among men with prostate cancer. For men with prostate cancer but not women 
with breast cancer, high use of symptom assessments, advice and the discussion forum were 
associated with high levels of symptom distress. For details, see paper II. 
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4.3. Study III 
Comparing Effects in Regular Practice of E-communication and Web-Based Self-
management Support on Symptom Distress, Anxiety, Depression and Self-Efficacy among 
Breast Cancer Patients. Preliminary Results from a Randomized Controlled Trial 
The objective of this study was to test and compare the effects of (1) secure e-mail service, (2) 
WebChoice (including the e-mail service), and (3) usual care; on symptom distress, anxiety, 
depression, (primary outcomes), and self-efficacy (secondary outcome), among breast cancer 
patients. Of the 522 breast cancer patients assessed for eligibility, 138 did not meet inclusion 
criteria, mostly due to lack of Internet access (see figure 7). Thirty-two were not approached 
for participation, mainly due to busy wards. Of the remaining 352, 176 agreed to participate, 
leaving a participation rate of 50% (176/352). Non-participants were older (did not meet 
inclusion criteria: median age 67; said no: median age 59 years), than participants (median 52 
years). Frequent reasons given for declining participation were lack of experience with 
computers/the Internet or that they had too much on their mind related to their illness. Nine 
patients were excluded due to incomplete baseline data, leaving a final sample of n=167. 
Patients were randomly assigned to the WebChoice group (n=64), the secure e-mail only 
group (n=45), or the usual care group (n=58). There were no statistically significant 
differences on demographic or psychosocial variables between participants in the three groups 
at baseline (Table 1, paper III). Among those with access to WebChoice, 64% (41/64) logged 
on more than once and 39% (25/64) sent e-mails to care providers (Table 3, paper III). In the 
secure e-mail group, 40% (18/45) sent e-mails. The e-mails were mainly answered by nurses. 
Of 153 e-mails, 22% (33/153) were passed on to and answered by physicians. Only one e-
mail was passed on to social workers. 
Both intervention groups were tested compared to the usual care group but not compared to 
each other. Linear mixed models analyses revealed that the WebChoice group reported 
significantly lower symptom distress (Mean diff: .16, 95% CI: .06-.25, P=.001), anxiety 
(Mean diff: .79, 95% CI: .09-1.49, P=.03) and depression (Mean diff: .79, 95% CI: .09-1.49, 
P=.03) compared with the usual care group (Table 2, paper III). The secure e-mail group 
reported significantly lower depression scores than the usual care group (Mean diff: .69, 95% 
CI: .05-.1.32, P=.03) but no differences were observed for symptom distress or anxiety. No 
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significant differences in self-efficacy were found among the study groups. For details, see 
paper III. 
Exploratory analysis comparing users (WebChoice: logged on twice or more; secure e-mail: 
sent at least one e-mail) and non-users of the interventions revealed no baseline differences on 
demographic or disease-related variables. There were no outcome differences between users 
and non-users of WebChoice or secure e-mail on symptom distress, depression or self-
efficacy. The users of the secure e-mail service had significantly lower scores on anxiety 
compared with the non-users (Mean diff: -1.28, 95% CI: -2.54 - -.01, P=.047). No such 
differences between users and non-users were observed in the WebChoice group. 
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5. Discussion 
This dissertation set out to contribute to the translation of evidence into clinical practice, 
addressing gaps related to uptake, use and effectiveness of eHealth interventions in practice. 
The discussion focuses on the main findings, but some additional findings are also discussed 
Strengths and limitations are discussed in methodology considerations, followed by 
significance for science and clinical practice, and recommendations for future research. 
5.1 Main results 
Results of this dissertation provide important new information and show how uptake of 
eHealth interventions creates new challenges for health care providers (study I). The 
dissertation also adds to evidence showing how different user characteristics are associated 
with different use of Web-based self-management support systems. Secure e-mail and advice 
were found to be much used components among cancer patients with high symptom burden 
and low social support (Study II). Further, the findings support the effectiveness of Web-based 
self management support, as WebChoice was effective in reduction of symptom distress, 
anxiety and depression among cancer patients (Study III). The secure e-mail component alone 
contributed to reduced depression scores, which is promising, as depression is highly 
prevalent and debilitating among cancer patients. An e-mail service is also much easier to 
develop and widely implement than more complex multi-component solutions. In summary, 
eHealth interventions can be an important contributor in provision of care and support for 
people with chronic illnesses. 
The result of the dissertation will be discussed organized by the RE-AIM framework, a 
framework designed to improve the likelihood of translation interventions into practice 
[16,26]. The aims of the dissertation mainly correspond to the Effect, Implementation and 
Maintenance dimensions. Additional results from the three studies are discussed as 
appropriate and also address the Reach and Adoption dimensions. 
5.1.1 Reach 
When eHealth interventions are offered, it is important to know who can be reached by these 
interventions. The Reach dimension in RE-AIM considers the representativeness of 
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individuals willing to participate in a study [16,188]. In study III, 50% of those eligible were 
reached (agreed to participate in the study). During the recruitment we were able to collect 
information about age, unmet inclusion criteria and reason for declining participation if 
known. Nearly one third did not meet the inclusion criteria, and the most frequent reason 
given was lack of Internet access (19%, 98/522). This was surprising given the Internet 
penetration in Norway, ranging from 90% to 94% during the recruitment period (2010-2013) 
[235]. Non-participants were older, compared to those included. Frequent reasons given for 
declining participation in study III were lack of experience with computers/the Internet or that 
they had too much on their mind related to their illness. Participants included in both study II 
and III had higher education levels than the average in Norway [236]. This corresponds to 
literature reporting younger age and having a higher education to be factors associated with 
more frequent health-related Internet use [88,90,237-240], suggesting that some demographic 
factors are still associated with ability and willingness to participate in eHealth studies. 
One way to increase the participation rates, and through this maybe to increase 
representativeness, might be to offer a demonstration of the interventions at the time of 
inclusion. In addition, simply to expose users to new interventions can contribute to use. This 
was experienced by nurses in study I, where some older patients were initially reluctant about 
the Choice intervention but became more interested when they tried it, and managed to use it. 
5.1.2 Effectiveness/efficacy 
The effectiveness dimension in the RE-AIM framework refers to the impact on important 
outcomes, including potential negative effects, and reflects the success of an intervention 
[16,188]. In study III, both the multi-component WebChoice intervention and the secure e-
mail service alone had significant effects on patients’ outcomes when they were offered as a 
part of a real-life situation.  
The findings that WebChoice reduced symptom distress as well as levels of anxiety and 
depression scores (Study III) are in line with previous research showing that Web-based 
interventions in cancer populations decrease depression and anxiety scores [78] and reduce 
symptom distress [7,76]. In addition, results showed a tendency towards increased self-
efficacy. This is promising given that study III entailed a relatively small sample from three 
diverse practice settings in regular care. One possible explanation for the significant results 
might be related to the unmet needs of cancer patients, such as needs within the domains of 
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communication, information, psychosocial, psychological and supportive care, which are 
reported to be highest during the treatment phase [241]. WebChoice allows patients to 
monitor their psychological, psychosocial and physical symptoms as well as to get 
individually tailored information and support on how to manage their symptoms through the 
advice component. The information component can offer educational information through 
access to other reliable Web sources. Through WebChoice, patients are also able to read the 
information more than once, when it suits them. Offering self-management interventions in 
this early phase might be especially helpful, as supported by the results from a study of a 
secure e-mail service similar to the one in study III, where the need for such a service was 
described as being most prominent during the first phase following hospital discharge [242]. 
Also noteworthy is the finding that access to the secure e-mail service alone reduced 
depression scores (study III). This is especially promising, as depression is debilitating and 
highly prevalent among cancer patients [243,244]. An e-mail service is also much easier to 
develop and keep up to date than more complex multi-component solutions. The e-mail 
service’s ability to reduce depression scores might relate to indications that patients with 
higher scores of depression, in addition to higher symptom distress and low social support, are 
high users of the e-mail service, as seen in WebChoice (Study II). The e-mail service is thus 
an intervention that is used by those with high illness burden, likely a group with high needs 
as well as high potential for improvement. The significant impact of access to secure e-mail in 
study III was detected despite different settings and variations in organization of care, which 
holds promise for secure e-mail services as interventions for reduction of depression scores 
among breast cancer patients, across settings. E-mail will hence be an important component to 
include in Web-based self-management support systems in the future. 
New in study III (i.e. compared to study II), was that the e-mail service was administered, and 
mostly answered, by nurses known to the patients. As most of the identified studies of e-mail 
communication effects deal with e-mail between patients and physicians [134], this 
dissertation adds important knowledge about a nurse-administered service. As part of practice, 
services administered by a group of nurses might be a model for offering e-mail 
communication between patients and providers. However, we do not know if services 
administered by a team of nurses, compared to services answered by a single health care 
provider (e.g. a physician), have a similar or different impact on patient outcomes. Likewise, 
we do not know whether the type of services has an impact on the number of messages 
received, topics in the messages, patient and provider satisfaction, or experiences with use. In 
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addition, how access to known compared to unknown providers may impact the results needs 
to be further examined. 
Whether a patient was a user or non-user of WebChoice (study III) was not connected to the 
observed effects on symptom distress, anxiety or depression. Similar results were observed in 
a previous study of WebChoice [7] and other studies of web-based support systems 
[158,160,181]. The findings of reduced scores on symptom distress, depression and anxiety 
(study III), despite just 64% of those with access to WebChoice being users, might relate to 
the psychological effects of the sheer possibility to use the system when needed. The 
opportunity to get the information needed for self-management of symptoms and problems, 
independent of time and location, may create a psychological effect that might contribute to 
the findings. Similarly, the reduction in depression scores among the secure e-mail group was 
detected although only 40% sent e-mails in this group. Interviews with non-users of a similar 
secure e-mail system revealed that even if they did not use the system, they liked having the 
possibility [245]. The assurance that someone is there for you, and can answer the questions 
important to you, might contribute to the effects observed on depression (study III). However, 
the mechanisms behind the effects of “possibility to use the system” are not known. For 
instance, no demographic or disease-related differences were observed between users and 
non-users in either intervention group, suggesting that other factors might be in play. 
Exploratory analyses of effects of the e-mail service, and relation to use/non-use, revealed that 
e-mail users had borderline significant lower outcome scores on anxiety than non-users. This 
might indicate that actual use of e-mail has a potential impact on reduction of anxiety 
symptoms. However, this result is based on a small sample and needs to be studied further. 
WebChoice is a system designed to support cancer patients in self-management of their 
illness. The system offers different components, so participants can use what they prefer 
without any push to use the entire system. In study II, different users (those who logged on 
twice or more) utilized different components, and made from two to 892 visits in the system. 
Users in study III visited WebChoice from two to 41 times. Whether dose of use impacts 
patients’ outcomes remains to be tested. However, this is not a straightforward analysis. 
Benefit does not necessarily correspond to total volume of use, but rather depends on the 
importance of the information or support provided. For example, reading advice for a very 
bothersome symptom just once may be enough to learn how to find relief, while reading 
postings on the discussion forum many times may help one feel good, but may not be equally 
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beneficial for managing symptoms. Reading advice once would be registered as low usage, 
engaging in the forum as high. How use of different components is connected to patients’ 
outcomes and dose of use remains to be tested. 
In recent years, several authors have discussed whether RCTs are the appropriate design for 
eHealth research [163]. The main argument against RCTs is that they take a long time to 
conduct. This is problematic within technology studies, as the development of technology 
moves very fast. Because  it often takes seven years from submission of the grant proposal 
until publication of the results of the study [246], the intervention studied risks being out of 
date when the results are finally available. In study III, some similar challenges were 
experienced. At the end of the study, some respondents reported that WebChoice was not of 
interest to them as it could not be operated using tablets, such as IPads. Similarly, the online 
discussion forum in study III was used less than in study II, possibly a result of other free 
applications being available, such as Facebook, offering services for social connection. 
Despite these challenges, positive results on patient outcomes were detected both in the 
WebChoice and in the secure e-mail group in study III. WebChoice contained components 
that might be more independent of technological innovations, such as updated advice on how 
to handle their specific symptoms and collections of links to trustworthy sources. In addition, 
secure e-mail communication with health care providers was offered, a service that still is not 
generally available in Norway. The speed of technology development, however, will continue 
to challenge design and methods to measure effects of eHealth interventions. 
5.1.3 Adoption 
Adoption concerns the number and representativeness of settings and intervention agents who 
are willing to participate in a given initiative [16,188]. To identify the potential for an 
intervention to work in a real-world environment, it is important to include information on the 
settings that adopt the intervention [16]. As described in the method section (study III), the 
initial collaborating hospital withdrew from study collaboration. Three of the next 10 hospitals 
invited to participate agreed to participate, resulting in an adoption rate of 27% (3/11). One of 
the reasons mentioned for not participating was lack of resources to answer e-mail from 
patients. This demonstrates some of the complexity of conducting eHealth studies in “real life” 
settings. Participating in a study is not the same as implementing secure e-mail in routine care, 
but this reason for declining should be acknowledged. It highlights the need for reimbursement 
systems, which are described as   accelerating the uptake of secure e-mail services in routine 
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health care [135]. However, we do not know if factors such as resources, expertise, interest and 
ability to implement the secure e-mail service contributed to willingness to participate for the 
hospitals that did participate in the study. More research is needed to address these topics. The 
adoption dimension can be challenging to assess by quantitative methods only and the use of 
qualitative data as in study III is recommended [26]. 
5.1.4 Implementation 
The implementation dimension in RE-AIM refers to the intervention agents' fidelity to the 
various elements of an intervention's protocol, and how the individual makes use of the 
intervention [16,188]. Although eHealth interventions have been shown to be effective, 
several implementation-related issues, such as varying levels of user adherence, non-usage 
attrition and high rates of dropout have been seen in many studies [21,22,141,142]. 
Consistent with previous research [146,155], prior computer experience made patients more 
likely to be users of WebChoice (Study II). In addition, individuals without other illnesses 
were more likely to use WebChoice than those with multiple illnesses. This is also consistent 
with previous studies suggesting that users of Internet interventions are healthier than non-
users [145,247]. Chronically ill people are also reported to be less eHealth literate [237] and 
may not regard web-based interventions as a suitable alternative for them, or they may be too 
ill to benefit. However, in study III, no differences could be found between users and non-
users in either the WebChoice group or the secure e-mail group on demographic or disease-
related variables at baseline. The influence of these factors may be less evident as Internet 
penetration are increasing in society [87,235]. Whereas demographic factors still play a role in 
who is available for web-based interventions (Study III), these factors might not impact who 
uses or does not use the system after agreeing to participate in a study/initiative. To make it 
possible to follow how demographic factors impact use of Web-based interventions, these 
variables should be included in future studies. 
About two-thirds of participants used the WebChoice intervention in study II and III. 
Consistent with findings from other studies [76,77], the usage was reported to be modest; 12 
visits (median) (study II) and seven visits (median) (study III). Even though website use is 
described as high initially and declining thereafter [62,71,160], we cannot compare the user 
frequencies for study II and III directly, as use was reported for 12 months in study II and for 
six months in study III. However, less use of web-based self-management support systems by 
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cancer patients in more recent studies was also noticed by Baker et al. [163]. The reasons for 
this are not known, but the availability of other channels for social interactions, such as 
Facebook and personal blogs, may play a role. Among users of WebChoice, results suggest 
that demographic and disease-related factors did not play a role in their user pattern, but 
several psychosocial variables did (study II). Participants with high levels of symptom distress 
and depression, indicating high illness burden, who also had low social support utilized the e-
mail service and advice component the most. This is consistent with studies reporting an 
association between lower levels of social support and symptoms of depression or negative 
mood with higher system use [150,153,154]. High illness burden accompanied by low social 
support might indicate a higher need for support compared to those who do relatively well, 
and these patients might have more to gain from e-mail communication. One way to tailor 
support to this group might be to screen for symptom distress, depression and social support 
to identify the need for support. More research is needed to explore how user characteristics 
and user patterns can provide guidance on the best ways to target interventions to groups of 
people. 
The e-mail service in study II was evaluated by patients in previous studies as a supportive 
and useful component [179,248]. Similar findings were revealed in a study of a Web-based 
diabetes support system showing e-mail communication with a nurse as an important reason 
for using the system [21]. Patients felt they received personal feedback and that the nurse 
looked after them. The possibility to communicate directly with a health care provider seems 
to be an important and highly valued feature across different patient populations. Study II 
suggests that this component may particularly appeal to people with high illness burden and a 
low level of social support, potentially due to a high wish or need for support, here provided 
through secure e-mail. User characteristics were not associated with high use of the forum, 
even though the forum was the component in which patients spent most time. It seems that a 
discussion forum may not be the place to turn to if one has little social support in addition to a 
high illness burden. This corresponds with the question of whether dose of system use is 
related to effects, as also discussed in 5.1.2. 
Men and women used WebChoice differently (study II), and this might indicate different 
needs for support and information. Low levels of social support were associated with high use 
of all components of WebChoice for women with breast cancer, but not for men with prostate 
cancer. In addition, high levels of depression were associated with high use of several 
components in WebChoice among women with breast cancer whereas high levels of symptom 
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distress were associated with high use among men with prostate cancer. Both gender and 
diagnosis may play a role in these differences, and differences in symptoms could also 
indicate variations in needs for support. For example, men with prostate cancer have been 
reported to use online support sites for information while women with breast cancer use them 
for emotional support [249,250]. To make it possible to test how gender affects use of such 
systems, studies that include men and women with similar diagnoses in the same studies are 
needed. As high illness burden and low social support are associated with high use of several 
components, this indicates that these characteristics are not barriers to use but rather may 
function as motivators for use. The same pattern has previously been seen in a study testing an 
interactive cancer communication system [154], and further insight into user characteristics 
and user patterns can provide guidance for targeting interventions to different groups of 
people. 
5.1.5 Maintenance 
The maintenance dimension of the RE-AIM framework refers to the extent to which an 
intervention is sustained, modified or discontinued after a trial period [16]. In the focus 
groups with nurses who had used Choice one year after a trial period (Study I), Choice was 
acknowledged as having several benefits for patients as well as nurses in terms of preparing 
both parties for communication, providing a shared engagement in care planning and giving 
the patient a voice. It also was reported to enhance the patients’ strengths, in line with 
findings reported by patients who had used Choice in another study [49]. Similar findings 
were reported in a study of the Edmonton Symptom Assessment System (ESAS), an 
assessment tool with some similarities to Choice [54], where most of the nurses found that 
ESAS enhanced patient care, helped patients to articulate their symptom issues, and facilitated 
follow-up of patients. Similarly, in a study of an electronic version of ESAS, clinicians 
reported it as useful [43]. This corresponds to one of the most important facilitating factors for 
maintenance of interventions; system usefulness/relative advantage [114,189]. According to 
Loscalzo et al [128], eHealth interventions are ready for implementation only if key 
professionals and administration understand the value of the interventions. The decision to use 
Choice in routine patient care was based on the perceived usefulness experienced by the 
health care providers at the units participating in the earlier trial [207], and the evidence of 
Choice’s effectiveness in reduction of symptom distress and reduction of the need for 
symptom management support [11]. The decision was supported by the nursing and medical 
59 
 
leadership at the units. The nurses in the study were thus familiar with the potential benefits 
and experienced several benefits after use in daily work. 
Some of the nurses noted, however, that even though they knew the advantages and 
possibilities Choice could offer, they still did not have their own “good experiences” using it. 
This impacted how often they used and followed up Choice assessment among their patients, 
and consistent with Rogers’ theory of “Diffusion of innovations”; that it is the individuals’ 
perception of the relative advantage of an innovation (in this case, what the users believe the 
relative advantage to be) that matters, not the experts’ objective evidence [189]. The greater 
the innovation’s perceived advantage to the user, the easier it is to adopt and sustain [189]. 
Workload benefits are described as facilitating factors in addition to benefits for patients’ 
outcomes [128,129].It became evident that Choice sometimes challenged rather than reduced 
the workload for some of the nurses, because several challenges were reported, such as fitting 
the Choice assessment and the follow-up conversation into the daily routines, as well as lack 
of time and space (Study I). 
Introduction of electronic communication tools may also require new ways to work and new 
competencies to perform new tasks. Through the use of Choice, the nurses described how 
patients were able to participate more in their own care and could thus contribute to “setting 
the agenda” when communicating their problems and preferences for care. Earlier, the nurse 
was more in charge of the conversation at patients’ admittance and if little time was available, 
the nurses sought less information. Likewise, the nurses addressed topics they were 
comfortable talking about and avoided challenging topics, e.g. being afraid to die or issues 
related to sexuality. A challenge that arose through use of Choice was nurses’ feelings of 
being overwhelmed by patients’ problems, without being able to help. Being unable to live up 
to expectations and demands at work is likely to foster feelings of powerlessness and threaten 
a professional’s self-image as a competent and responsible nurse. Incompatible demands, 
stress of conscience and lack of support from managers and colleagues are strongly associated 
with burnout and job turnover [251]. This highlights the complexity of introducing a new 
technical tool into practice, as it alters forms of interaction between people [252]. Leaders 
have to be prepared for unexpected changes, such as needs for user support that may arise 
after the introduction of a new tool like Choice. In addition, nurses need to be aware that it 
may not be possible to help patients with all their symptoms and concerns. It could be argued 
that some problems are and should remain outside the hospital’s sphere of responsibility 
[253], or could be handed over to other professionals (e.g. social workers) or caregivers. 
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Nurses are however trained to intervene, and nursing interventions are seen as a key function 
in the nursing process. Furthermore, nurses are not necessarily aware of their facilitator role, 
such as helping patients mobilize their own strengths. Educating nurses in these important 
issues may help foster professional confidence, even if they are not always able to solve the 
problem for the patient. 
Findings from study I clearly underscore that, to successfully implement and maintain eHealth 
interventions in daily practice, the users must recognize that eHealth interventions are 
beneficial in their daily work and for the patients [119,254]. Understanding a tool’s utility 
affects the motivation to use the system as well as to encourage participation [19]. Further, the 
focus group discussions with the nurses underscored that this understanding of user usability 
is important for maintenance of a program until it is fully integrated into daily routines. 
Choice promoted a shift towards more patient-centered care by inviting the patients to 
participate actively in their own care by assessing their own symptoms, preferences and 
needs. Since it is natural to return to old routines during periods of time pressure, one must 
establish routines that initiate, integrate and protect patient-centered care in daily practice 
[255]. An unexpected finding in study I was that Choice challenged ethical and knowledge-
related skills more than technical ones. When introducing new eHealth interventions in 
clinical practice, leaders have to be prepared for unexpected changes, such as needs for user 
support. Needs for new competencies may also arise. 
5.1.6 eHealth in regular care? 
Providing new ways for self-management support and communication is essential as society 
faces increasing incidence of chronically ill patients [1]. This dissertation adds to the growing 
body of evidence supporting Web-based self-management support interventions as effective 
for patient outcomes in cancer populations (Study III) [7,76-79]. However, the impact of such 
interventions depend not only on effectiveness, but also on the extent to which interventions 
reach the targeted group, and the extent to which they are implemented and maintained in 
clinical practice. This dissertation illustrates the feasibility of offering parts of Web-based 
interventions in regular care, as the secure e-mail component was answered during regular 
working hours, by nurses and physicians at the hospital where the patients were treated (Study 
III). This provided patients with easy access to the expertise without a face-to-face 
appointment. There still might be factors such as age and lack of access to the Internet that 
play a role in who can be reached by Web-based interventions (Study III). However, as access 
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to the Internet increase in society [235], a larger group of the population will have the 
opportunity and skills to make use of Web-based support. 
However, this dissertation also reveals challenges that might occur during the introduction of 
eHealth interventions into regular care (Study I). Integrating new routines such as secure e-
mail can be also challenging, and skepticism among care providers about use of secure e-mail 
in routine care exists [256,257]. Fear of potentially being flooded with messages leading to an 
increased workload [118,135,174], and not being reimbursed for the time spent responding to 
messages [113,258,259] are well-known concerns. Concerns about increased workload were 
also mentioned as reasons for not participating when hospitals declined participation in study 
III. Lessons learned, however, are that patients do not send many e-mails to their health care 
providers (Study II and III). These results are in line with other studies showing e-mail 
volume to be low [129,174,260], and indicate that secure e-mail should be manageable and 
possible for health care providers to handle. In addition, the e-mail service was highly used by 
patients with high illness burden combined with low social support (Study II), indicating that 
this could be a good way to provide support to this group. 
In a time with growing complexity in care, new ways to communicate and provide support are 
needed. In Norway, people seem to expect a future with more eHealth services [88]. Patients 
also expect to be able to communicate with their health care providers through e-mail 
[256,261,262]. To meet these expectations, we need to provide systems that are easy to use, 
useful to patients, and possible to implement and maintain in clinical care. Fit with regular 
workflow was described as one challenge among nurses who used Choice in regular care 
(Study I). The secure e-mail service in study III was administered by a team of 3 to 4 nurses at 
each location, trained and responsible for answering the e-mails. The e-mails thus did not 
interfere with the workflow of the whole staff, which might make the service easier to 
implement and maintain. The nurses performed the new task of answering the e-mails during 
regular working hours, without any incentives, indicating that the e-mail service could be a 
feasible means of communication between patients and nurses or physicians. The e-mails 
were primarily answered by nurses and were only passed on to physicians if needed. The 
nurses answered the majority (78%) of the e-mails, with physicians answering the rest (22%), 
indicating that the e-mail service can successfully be managed by nurses as the first line of 
response. Further, as nurses are described as having a holistic approach to patients, focusing 
on emotional issues, consequences of disease and illness information [263], they are well 
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equipped to answer questions and concerns from patients. Nurses have also been found to be 
sensitive and able to respond well to emotions expressed through e-messages [264]. 
eHealth interventions such as Web-based self-management support and communication 
interventions allow patients to be involved in their own care and decisions regarding health, as 
increasingly requested by patients [29]. However, as revealed in study I, introduction of new 
eHealth interventions in clinical practice can lead to a need for support and new competencies 
to make it possible to perform the new tasks. Leaders have to be prepared for unexpected 
changes that may arise in order to take advantage of the possibilities offered through eHealth 
interventions. To foster uptake of effective eHealth intervention in clinical practice, health 
care providers must have the necessary skills to operate these systems, and systems for 
reimbursement should also be considered. 
5.2 Methodological considerations 
Originally, it was planned that all data in this dissertation would be obtained from study III. 
However, as described in the method section, the initial collaborating hospital withdrew just 
before patient recruitment was about to start, resulting in a significantly delayed start-up of 
study III. The decision was therefore made to include two additional studies (study I and II) to 
make it possible to study factors important for translation of eHealth interventions into 
practice, specifically to examine effectiveness, use and uptake of eHealth interventions. The 
pragmatic decision [194] to include heterogeneous materials from three different studies may 
limit the generalizability of the results because the different dimensions in RE-AIM were not 
addressed within one study. However, the main results complemented by additional findings 
from the three studies offer richness in different aspects of eHealth and address all dimensions 
of the RE-AIM framework, strengthening the dissertation results and identifying new 
questions for future research. The combination of the three studies also provides a broad 
picture of factors important for uptake, use and effectiveness of eHealth interventions. The 
findings from the three studies supplement and support each other, contributing unique 
information to the field of eHealth. A multi-method approach introduces methodological 
challenges and involving experts within each type of methodology is of essence [199]. For 
this dissertation, a team of researchers with expertise within the different methods was 
therefore established. The opportunity to be in an environment with experts on quantitative 
and qualitative methods, IT developers and statistical experts both made the multi-method 
approach in this dissertation possible and provided an excellent training opportunity. 
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In the following, methodological considerations related to the three different studies are 
discussed. 
5.2.1 Study I  
Study I was a qualitative study using focus group interviews and a qualitative content analysis 
to explore nurses’ experiences of benefits and barriers to maintaining use of Choice in clinical 
practice. 
5.2.1.1 Researchers’ pre-understanding 
In qualitative research, results and process are formed by the researcher perspective. As the 
researcher is instrumental in both collecting and analyzing data, it is important to be aware of 
one’s own pre-understanding and qualifications [265, p566]. According to Malterud [266] 
these pre-understandings include personal and professional experiences and qualifications, 
beliefs about how things are and what is to be investigated. Pre-understandings are not the 
same as bias, but need to be mentioned and considered throughout the research. As the 
principal investigator of this dissertation, my experience and qualifications for conducting 
focus groups are based on experiences from managing and leading groups as a nurse leader as 
well as through leading group therapy sessions for people with drug addiction. I have also 
completed courses in qualitative methods and group leadership. 
The team of researchers that developed the interview guide and conducted the focus groups 
were familiar with the units and the implementation process for the Choice intervention. This 
might have influenced the interviewer’s pre-understanding and may have impacted the 
participants’ willingness to discuss challenging issues. On the other hand, this knowledge 
provided insight into what questions were important to ask and which statements needed 
elaboration. As the nurses raised several sensitive topics during the focus groups, this could 
be considered both a strength and a limitation. The researchers who conducted the analyses 
had not been involved in the implementation or follow-up process of the Choice intervention. 
As such, the material from the focus groups could be analyzed with “fresh eyes”, without the 
influence of previous history. 
5.2.1.2 Trustworthiness  
Trustworthiness is regarded as the gold standard for qualitative research [219, p.430], and has 
parallels to the standards of reliability and validity in quantitative research. To ensure 
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trustworthiness of this study, the design, participants, procedure for data collection and 
description of analyses are provided in the method section of the dissertation. Core concepts 
in trustworthiness are credibility, dependability, confirmability and transferability [219, 
p.430]. Even though we separate the different aspects of trustworthiness, they should be 
viewed as intertwined and interrelated [217]. 
Credibility, a parallel to internal validity in quantitative research, deals with the focus of the 
research and refers to confidence in how well data and processes of analysis address the 
intended focus [219, p.430]. The participating nurses in study I had experiences with use of 
Choice in routine care and, as such, gave us insight into real-life use of the intervention. The 
breadth of the sample in experience, age, gender and unit employment also strengthens the 
study, shedding light on topics in the focus groups from various perspectives. Focus group 
interviews were chosen as the method for data collection based on the qualities of both 
interviews and discussions [213] as well as the benefit from group dynamics [214]. 
Credibility was achieved through the participants’ opportunity to challenge and verify each 
other’s opinions during the focus group discussion. In addition, experienced and less 
experienced nurses were divided into separate groups so that experienced nurses did not 
dominate the discussions [215]. Further credibility was ensured through providing sufficient 
time to collect and analyze the data. In addition, a researcher experienced in qualitative 
methods with no previous knowledge of Choice or the implementation process was part of the 
analyzing process. 
Dependability refers to the stability of data over time and conditions, and corresponds to the 
stability aspect of reliability in quantitative studies. Data for study I were collected over a 
brief period of five weeks, which should reduce the risk of inconsistency which may arise 
when data is collected over a long time. However, because the nurses were asked for their 
experiences of using Choice during the last year, this might have impacted their recall of 
experiences. 
Confirmability corresponds to the reliability objectivity aspects in quantitative studies 
[219,p430]. The involvement of an external researcher contributed, in addition to credibility, 
to better ensure dependability and confirmability in the study. The analyzing process also 
included discussions with other researchers, to strengthen credibility and dependability. In 
addition, a thorough description was provided of the collection of data and of how the 
analysis was performed, including examples of the process from meaning units to themes 
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(Table 4). However, because a text never implies just one meaning, but rather the most 
probable meaning from a particular perspective [216, p.28], our interpretation of the findings 
should be seen as one possible understanding of use of Choice in clinical cancer practice. 
Transferability refers to the extent to which findings can be transferred to other settings and 
groups, and corresponds to the concept of generalizability in quantitative studies. Participants’ 
demographics and context are described in depth in the method section to help readers judge 
transferability [219, p.435]. Since the findings are context specific and different interventions 
have different characteristics, these results are not necessarily transferrable to other contexts 
and eHealth interventions. The study findings are also limited to nurses’ experiences of use. 
Having input from other health care providers using Choice (e.g., physicians) would provide a 
more comprehensive picture of clinicians’ experiences. However, this was not feasible at the 
time, and as nurses were in the frontline using Choice, we chose to gain information from this 
group. In addition, input from unit leaders could add to this picture, as has been done by one 
of our colleagues (results currently under review). 
5.2.2 Study II 
5.2.2.1 Design 
Study II was an exploratory secondary analysis of a previous RCT [7]. An important aspect in 
secondary analyses is to evaluate the quality of the data [219, p.236]. A strength of this study 
was the access to the original study protocol and description on how data were collected. In 
addition, the original questionnaires filled in by the patients at baseline, the complete SPSS 
data files and a detailed log of how the participant used WebChoice and the separate 
components, were available. Access to such detailed study information provided an excellent 
opportunity to assure the quality of data used to explore user characteristics and user patterns. 
5.2.2.2 Study sample 
Study participants were self-selected, recruited through advertisement and pamphlets and had 
to have Internet access. As higher education and Internet access are associated with higher 
willingness to participate in research studies, use of the Internet, the above-mentioned factors 
may limit generalizability. The participants in the study were younger than the average age of 
patients diagnosed with prostate and breast cancer in Norway [267,268]. A self-recruited 
sample could also mean a highly motivated sample, which again might limit generalizability. 
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However, potential users of Web-based support systems have to be interested and motivated 
for use, and we therefore assume that our sample is representative of the target population 
(breast cancer patients with access to the Internet), but might not be representative of cancer 
patients. Another limitation to generalizability is that we do not know if the observed 
differences between breast cancer and prostate cancer patients were related to the two 
diagnoses or to gender. Therefore, to clarify this, future studies should include patients with 
cancer diagnosis that are non-gender specific. 
5.2.2.3 Method for data collection and outcome measures 
Because all respondents had completed baseline questionnaires before being randomized into 
the two study groups, there were no missing data for the baseline questionnaires used in the 
secondary analyses in study II. Data from the server log provided detailed information on 
overall and component-specific use of WebChoice on individual and group levels, allowing 
for the types of analysis presented here. The outcome measures included in the analysis were 
based on the available data, and as this was an exploratory study, all outcomes and their 
association with system use were tested. 
5.2.2.4 Data analysis 
The use of a robust new method to identify subgroups that share specific characteristics; 
Latent Class Analysis (LCA) [225], adds to the strengths of the study. To our knowledge, 
LCA had never been used to analyze use patterns of eHealth interventions before, and hence 
adds to methods that can be used for this purpose. The relatively small sample, however, put 
some constraints on the choice of statistical models and we chose to stratify all statistical 
models by diagnosis/gender, thus making the comparison groups even smaller. In addition, 
the prostate cancer group was smaller than the breast cancer group, which may have further 
limited statistical power. The small sample size also reduced the number of variables that we 
were able to include in the LCA models. Given the limited statistical power, we chose to 
categorize our variables using tertiles and in doing so, we might have lost some information 
on differences in the underlying population. On the other hand, when fitting the models with 
categorical variables we were able to detect a direction in how low or high scores were 
associated with different use patterns. 
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5.2.3 Study III 
5.2.3.1 Design 
Study III involved an RCT, comparing effects of WebChoice and secure e-mail to usual care 
among breast cancer patients. Due to the nature of the interventions, participants were not 
blinded to group allocation. Patients completed baseline questionnaires before randomization, 
hence their group assignment did not impact any baseline responses. Knowledge about 
whether they are receiving the intervention or not may impact the way respondents feel, and 
as such also their subjective assessment on follow-up questionnaires [269]. 
The randomization was performed by an external research office, independent of researchers 
and clinicians in the study, avoiding selection bias. The block size (42 - stratified by site) was 
not known to the researchers before analysis of the data. Because the initially calculated 
sample was not obtainable, the large block size caused differences in the number of 
respondents in the three study groups. A lesson learned is to define smaller block sizes in 
future studies because recruitment to eHealth studies is sometimes lengthy and reaching all 
individuals can be challenging. However, the effect sizes in the study were larger than 
anticipated and statistically significant differences could be detected nevertheless. 
5.2.3.2 Study sample 
Among the strengths of this study is the inclusion of a sample with cancer diagnosis verified 
in the medical record. Many Web-based studies rely on self-report of diagnosis, which may 
reduce the accuracy of the sample description and impact the generalizability of results. As 
mentioned in the discussion of the Reach dimension, a limitation in the study was that 
participants were younger than those declining participation, with higher than average 
Norwegian education levels, suggesting that they were not representative. On the other hand, 
the patients were recruited from three different hospitals across the country, increasing 
generalizability of findings across practice settings. 
Another generalizability limitation involves the retention rates. During six months of follow-
up, a 14% (24/167) withdrawal rate was observed. This is lower than the withdrawal rates of 
21% to 23% described in reviews of Web-based interventions [156,157]. As in other studies 
[6,62], higher withdrawal rates, albeit not statistically significant, were observed in the 
intervention groups than in the usual care group (WebChoice: 16% (10/64); e-mail 18% 
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(8/45); usual care 10% (6 /58)). There was however no association between baseline 
characteristics and study attrition. 
Intervention adherence, a known challenge in eHealth research [22] reflects another study 
limitation. In the WebChoice group 64% logged on to the intervention more than once, and 
40% in the secure e-mail group used this service. However, there were no differences between 
users and non-users in either group on any demographic or disease-related variables, and 
because results detected in study III were mostly unconnected to whether a patient was a user 
or not, low intervention adherence might not have represented a large problem in the study. 
Finally, the included sample was fairly homogenous, including women with breast cancer 
within the first year of diagnosis (median 1 month after diagnosis). Nearly 50% of the 
participants were included immediately after diagnosis. However, the other half was included 
from one to ten months post diagnosis. Participants were thus in different phases of treatment 
and experienced different side effects at the time of questionnaire completion. This might 
have influenced the symptoms reported on the MSAS and HADS. The small study sample did 
not permit subgroup analysis of the effectiveness of the interventions at different treatment 
phases, and this is a topic for further exploration. On the other hand, this variability in time 
since diagnosis could strengthen the results regarding the intervention’s effect, suggesting 
generalizability across treatment time. 
5.2.3.3 Method of data collection and outcome measures 
If no response was received to questionnaires within two weeks, a letter with a reminder was 
sent once but participants were also informed that they could withdraw from the study at any 
time. It was important for us to minimize the possible additional burden that participating in a 
study might cause, particularly as the participants included in this study were in a stressful 
phase; recently diagnosed with breast cancer and undergoing treatment. This procedure 
ensured that minimal pressure was put on participants to complete questionnaires. This could 
however have contributed to the observed withdrawal rate. 
A strength of the study is that the questionnaires were first tested among 15 pilot participants 
in order to detect weaknesses before RCT start-up. The questionnaires were found to perform 
well. However, when checking data before analysis, it was observed that the MSAS was not 
always fully completed. Several of the respondents did not fully rate symptom frequency, 
severity, and distress. We were able to calculate instrument scores based on the available data 
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according to guidelines. However, this indicates that MSAS can be challenging to complete 
for some respondents. One way to ensure more completed questionnaires might be to offer 
information at baseline collection on how to fill in the form. If this is not possible, another 
way may be to use the MSAS short form instrument that only asks for rating of symptom 
distress. 
All SPSS data entry was double-checked. Chronbach’s alpha coefficient (ranging from 0.76-
.0.96) was calculated to check that the instruments had acceptable internal consistency and 
reliability (see the method section for details). It should however be noted that repeated use of 
the same instruments every two months could have led to memory effect in the respondents’ 
answers. 
A possible weakness of self-reported questionnaires is the process of retrieving information 
about symptoms from memory. To minimize this weakness, the instruments MSAS and 
HADS ask for the respondent’s experience during the last week. 
5.2.3.4 Data analysis 
Among the strengths of the study is the use of an intention-to-treat approach and the use of 
linear mixed models for repeated measures to analyze changes over time. This modern 
statistical method allows usage of all available data at each time point and can handle missing 
data without the need for imputations. 
A limitation, however, is that a smaller sample size than initially calculated combined with 
the withdrawal rate during the study reduced statistical power for analyses. Because 
participant inclusion had to be stopped before the a priori calculated sample size was 
obtained, block randomization led to different sample sizes in the three groups, with the 
fewest participants in the secure e-mail group. In addition, the e-mail group had the lowest 
number of completers of questionnaires at six months. The limited study size calls for 
additional research to further confirm the results. Post hoc analysis of usage and its relation to 
outcomes was based on an even smaller sample, comparing users and non-users, and must be 
viewed as an exploratory analysis only. 
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5.3 Contribution to science 
This dissertation provides important insight into factors essential for translation of eHealth 
interventions into regular care. The use of the RE-AIM framework guides the dissertation by 
directing the focus to aspects important in design as well as evaluation of eHealth 
interventions. 
Study I adds knowledge and contributes to bridge the gap between research on eHealth 
interventions effective in clinical trials and maintenance of such interventions in regular 
clinical practice. The findings add information about experienced benefits from, and barriers 
to, the uptake of an interactive tailored patient symptom assessment and communication 
intervention, as experienced by nurses. To implement and maintain use of the advantages of 
eHealth interventions, it is important to acknowledge the benefits of the intervention and be 
willing to change routines and competences. 
In study II, a method new to the evaluation of eHealth interventions was introduced to analyze 
user patterns: Latent Class Analysis (LCA). LCA was found to be a useful technique to 
identify subgroups of users through enabling detection of clusters of user characteristics 
linked to use of different Web Choice system components. The findings showing patients 
with high symptom burden and low social support to be high users of secure e-mail 
correspondence with cancer nurses can provide important knowledge when aiming to better 
tailor interventions in the future. LCA can be recommended in future studies of user patterns 
of eHealth interventions. 
Study III adds to the limited literature on eHealth intervention components and their 
contribution to effect by comparing a single component to multiple components of a Web-
based self-management support intervention. Results from study III support the growing 
evidence of significant positive effects from Web-based self-management support on patient 
outcomes for cancer patients. The positive effect of the secure e-mail service alone on patient 
outcomes highlights the potential of this component, both as part of multi-component 
interventions and as a stand-alone service. Study III collected data on most dimensions of RE-
AIM and is thus an example of how the framework can enrich the reporting of eHealth 
studies. In addition to its results on patients’ outcomes, this study draws attention to some of 
the challenges facing eHealth research, including recruitment of participants and the rapid 
technological development challenging design and the types of methods to use. 
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5.4 Implication for clinical practice 
The findings from this dissertation have multiple implications for clinical practice, as they 
confirm that eHealth interventions can improve patient outcomes. In addition, this dissertation 
elicited factors important for maintaining eHealth interventions in regular care. 
Dissertation findings show that interactive tailored patient assessment tools such as Choice 
can be implemented into regular care, are seen as helpful for patients and nurses in eliciting 
symptoms, increase patient participation and enhance communication between patients and 
nurses. This suggests that more widespread use of such tools could improve the quality of 
care for many patients. 
However, this dissertation also revealed that implementation and use of electronic support 
tools in regular care is not straightforward. To implement and maintain use, it is important to 
be aware of new challenges that may arise in the use of technology that are not necessarily 
related to the technology itself. These challenges include the need for better communication 
skills and competencies in patient-provider interactions revealed in study I, role changes, lack 
of time, inter-professional and cultural issues and the need for changing routines. Addressing 
such challenges and being prepared for unexpected consequences are crucial for successful 
implementation of new eHealth interventions into clinical practice.  
Web-based self-management support, through its ability to reduce symptom distress, 
depression and anxiety scores, can be a contributor to care for breast cancer patients and 
likely also for patients with other chronic illnesses. The fact that secure e-mail services, 
shown to reduce depression scores, can successfully be managed and responded to by nurses, 
holds promise that such services can feasibly be introduced into regular care and have great 
potential as communication channels between patients and health care providers. Nurse-
administered e-mail services have the potential to reach large groups of patients and they 
could be offered in routine care in addition to traditional face-to-face and telephone services. 
This will also meet patients’ growing interest in using e-mail communication with health care 
providers, and can contribute to improvement of patient outcomes through a relatively 
“simple” intervention.  
We might however still have a long way to go before eHealth interventions, shown to be 
effective in clinical studies, are implemented and maintained in clinical practice. As observed 
in study III, only three of the 11 hospitals approached agreed to participate in the study. These 
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hospitals were not asked to implement the secure e-mail service as routine clinical practice, 
only to participate in a study for a limited time. The hesitance to participate highlights how 
hard it can be to introduce new interventions and change existing ways to work. eHealth 
interventions that only include patients may have a greater potential for being widely adopted 
than interventions requiring actions from health care providers. However, as the opportunity 
to communicate with health care providers is associated with positive impact on patient 
outcomes, incentives are needed for implementing such technologies and placing greater 
emphasis on factors that motivate changes in routines and implementation of new 
interventions. 
Today’s health care system is continuously faced with implementations of new interventions 
and systems. Results from this dissertation suggest that there is a need for new routines and 
competencies in order to benefit fully from the possibilities offered through eHealth 
interventions. Health care providers should also be active participants in the development and 
work processes related to these interventions to make them fit in the routine care settings. To 
improve competencies and attitudes as well as to increase willingness towards use of eHealth 
interventions, education about such interventions and how to make use of them should also be 
a part of the education of health care providers in the future. In addition, to speed up 
translation of effective eHealth interventions into clinical practice, health care managers need 
knowledge of these interventions and, through education, need to be provided with skills to 
implement and maintain new solutions. 
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5.5 Recommendations for future research 
This dissertation highlights several aspects where further research is needed. More studies are 
needed to test long-term effects of Web-based self-management support, as well as whether 
there are special phases in the treatment of cancer where such interventions are especially 
effective. The observed effects of WebChoice in study III on reduction of symptom distress, 
anxiety or depression were detected although only 64% of participants were users of the 
system. In line with other studies, whether a patient was a user or non-user was not connected 
to the observed effects [7,158,160,181]. This might relate to the psychological effects of 
having the possibility to use the system if needed. However, the mechanisms behind this are 
not known and need further exploring. In addition, how the use of various components, other 
than secure e-mail, is connected to patients’ outcomes, as well as how many components are 
needed to achieve positive effects, remains to be tested. 
In study II, a high level of computer experience and no additional illnesses besides cancer 
increased the probability of using WebChoice. No such associations were observed in study 
III however, indicating that examining which factors influence whether a person becomes a 
user or not is of importance for research. Study II identified people with high symptom 
burden accompanied by low social support as high users of the secure e-mail and advice 
components. Further insight into user characteristics and user pattern can provide guidance for 
targeting interventions to different groups of people. 
Like the observed effects in the WebChoice group, reduction of depression scores in the 
secure e-mail group was not connected to whether a person used the system or not. The 
exploratory analyses of the secure e-mail group revealed that those who sent e-mail, 
compared to non-users, had a reduction in anxiety scores. Further studies are needed to 
confirm these exploratory results. How the option to communicate with health care providers 
might impact well-being is another topic for further studies. 
In study III, the secure e-mail service was administered and mainly answered by nurses at the 
hospital where patients were treated. Further studies are warranted to test whether services 
administered by a team of nurses, compared to services answered by a single health care 
provider (e.g. a physician), have a similar or different impact on patient outcomes. Similarly, 
there is a need to explore whether the type of service has an impact on the number of 
messages received, topics in the messages, patient and provider satisfaction and experiences 
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with use. How access to known providers can affect the results, compared to services with 
unknown providers, is also a topic for further research. 
Based on findings from study I, exploring nurses’ experiences of the use of Choice in regular 
care, future research could benefit from conducting qualitative studies examining health care 
providers’ experiences of use of eHealth interventions. As eHealth interventions are often 
complex systems, it is important to study user experiences as well as effects on patient 
outcomes. To obtain a broad picture, it will be important to include different groups of health 
care providers that use the intervention. This again can help identify facilitating factors to 
implementation and maintenance of the interventions. 
Similar to the recent observations by Baker et al. regarding reduced system use of Web-based 
self-management support systems [163], less use of WebChoice was observed in study III 
than study II. Reasons for this are not known, but the availability of other channels for social 
interactions, such as Facebook and personal blogs, might provide some explanation. However, 
this needs to be further studied to make it possible to develop eHealth interventions that offer 
components of interest to the potential users. 
Finally, the rapid pace of technical development will continue to challenge design and 
methods measuring effects of eHealth interventions. There is a need to speed up eHealth 
research to keep up with technological development, which in turn requires a focus on 
methods facilitating more rapid inclusion of study participants, as well as more studies on 
tailored interventions. 
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6. Conclusions 
This dissertation suggests that, from nurses’ perspectives, integration of interactive tailored 
assessment tools in clinical practice offer many benefits for communication and enhancement 
of patients’ strengths, contributing to patient-centered care. However, to reap these benefits, 
use of such tools must receive equal priority to other routines and requires sufficient time, 
space and competence. 
This dissertation also provides evidence that different user characteristics are associated with 
different use patterns of Web-based self-management support. Such information is crucial in 
order to target Web-based support systems for different patient groups. In study II, e-mail and 
self-management advice were highly used components for patients who had low levels of 
social support and high illness burden, suggesting that patients with these characteristics may 
find such tools particularly useful. 
Finally, this dissertation shows that a Web-based self-management support intervention can 
be an important contributor in care for breast cancer patients, through reduction of symptom 
distress, anxiety and depression scores. The secure e-mail component alone contributed to 
reduced depression scores, which indicates that secure e-mail can be an important part of 
multi-component systems and can also effectively be offered as a stand-alone service. Despite 
the concerns identified in the literature that health care providers will be flooded by messages 
if they offer e-mail services, only modest use was observed in study II and III, indicating that 
e-mail is manageable to integrate in routine health care. 
In summary, through multi-study and multi-method findings, this dissertation provides 
important new information on aspects of uptake, use and effectiveness of eHealth 
interventions. The results and knowledge gained can be used to significantly improve and 
inform the process of designing systems, conducting research and implementing and 
maintaining eHealth interventions in routine health care. 
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Connect-Prosessevaluering Choice 
Side 1 av 2 
 
FORESPØRSEL TIL HELSEPERSONELL OM DELTAKELSE I 
DISKUSJONSGRUPPE 
PROSESSEVALUERING CHOICE 
 
 
Du blir herved forespurt om å delta i en diskusjonsgruppe hvor vi ønsker å få tilbakemelding 
på hvorvidt vi har nådd de målene vi satte oss med Choice, eller om det er områder vi kan 
forbedre både mht. selve verktøyet og implementeringen. 
 
Diskusjonsgruppen inngår som en del av en større studie; CONNECT (Care Online: Novel 
Networks to Enhance Communication and Treatment), om å utvikle og teste en tilleggsmodul 
til elektronisk pasientjournal (EPJ) for kommunikasjon og informasjonsutveksling mellom 
pasient og helsepersonell. 
 
Hensikten med CONNECT er å: 
1. Utvikle og teste CONNECT, en tilleggsmodul til EPJ for kommunikasjon og 
informasjonsutveksling mellom pasient og helsepersonell.  
2. Utforske krav og utfordringer knyttet til bruk av felles elektronisk pasientjournal 
gjennom mobile terminaler (for eksempel mobiltelefoner). 
3. Kartlegge hvilke behov pasienter og helsepersonell har for dokumentasjon, 
informasjon og felles data for å understøtte pasientmedvirkning, behandling av 
sykdom og gi kontinuitet i sykepleie. 
4. Kartlegge om standardiserte terminologier for helse kan benyttes i pasientens journal. 
Utvikle verktøyer som kan oversette mellom pasientvennlig språk og termer benyttet 
av helsepersonell. 
 
Deltakelse i diskusjonsgruppen varer i ca 2 timer. Opplysninger som fremkommer vil 
benyttes i videre utvikling av Choice og CONNECT, samt frambringe kunnskap om hvordan 
verktøy best kan innføres i praksis. 
 
Diskusjonsgruppens innspill vil bli tatt opp på lydbånd. Utfylte skjema og lydbåndopptak vil bli 
oppbevart i et låst arkivskap ved Senter for pasientmedvirkning og sykepleieforskning. 
Innspillene dine vil bli behandlet konfidensielt. Alle data vil bli avidentifisert, og ingen svar vil 
kunne tilbakeføres til deg som person når resultater skal presenteres. Rikshospitalet HF vil 
behandle opplysningene i samsvar med gjeldende lovverk. 
 
Selv om du sier ja til å delta, kan du trekke deg når du måtte ønske det, uten å oppgi noen 
grunn, og uten at det vil ha noen konsekvenser. Dine data vil da bli slettet. 
 
Vi regner med at studien i sin helhet vil være avsluttet etter 2015. Alle data vil være slettet 
senest 10 år etter dette, dvs. før 31.12.2025. Du har rett til innsyn i hva som er registrert av 
opplysninger om deg og til å kreve at eventuelle feil rettes. 
 
 
Om du har spørsmål om deltakelse eller selve studien kan du ringe prosjektleder Professor 
 Cornelia M. Ruland ved Senter for pasientmedvirkning og sykepleieforskning og på telefon 
23 07 54 60. 
 
 
 
 
 
 
Connect-Prosessevaluering Choice 
Side 2 av 2 
Samtykkeskjema 
 
Ta vare på første side av dette samtykkeskjemaet.  
 
 
 
Jeg samtykker i å være med i diskusjonsgruppen slik den er beskrevet ovenfor. Jeg er 
informert om at min deltakelse er helt frivillig. Selv om jeg sier ja til å delta i dag, kan jeg 
trekke meg når jeg måtte ønske det, og uten at det vil ha konsekvenser for meg . 
 
 
 
Dato:___________ 
 
 
 
         
Navn: (blokkbokstaver): 
 
 
 
         
Signatur 
 
  
FORESPØRSEL OM DELTAKELSE I STUDIEN 
 
Internett-støtte til kreftpasienter 
 
Du blir herved forespurt om å delta i en studie som utgår fra Rikshospitalet – 
Radiumhospitalet HF med støtte fra Kreftforeningen. Hensikten med studien er å (1) få mer 
kunnskaper om informasjons- og støttebehov til mennesker som har fått kreft slik at de kan 
møtes bedre, og (2) teste nytten av en Internett-basert informasjons- og støttetjeneste for 
kreftpasienter, kalt WebChoice.  WebChoice gir informasjon og veiledning som er 
skreddersydd til den enkelte pasients problemer og informasjonsbehov via Internett. Videre 
kan en ta kontakt med en kreftsykepleier som vil svare på spørsmål, eller med andre 
pasienter i samme situasjon. 
 
Om du velger å delta, vil du være med i studien i 12 måneder. Det innebærer at vi vil sende 
deg spørreskjema i posten i starten som omhandler noen spørsmål om din helse og 
informasjonsbehov og igjen etter 3, 6, 9 og 12 måneder. Vi vil be deg fylle det ut og returnere 
til oss i en vedlagt ferdig frankert konvolutt. 
 
Etter vi har fått tilbake spørreskjema sammen med dette skjema som kalles ”Informert 
samtykke” undertegnet av deg, vil du bli trukket ut til å tilhøre en av to grupper. Vi kan 
dessverre ikke påvirke hvilken gruppe du vil tilhøre. Dersom du blir trukket ut til den første 
gruppen vil du få adgang til Internett-tjenesten umiddelbart. I så fall vil vi sende deg alt du 
trenger for å komme i gang med å bruke tjenesten.  
 
Et mindre utvalg av pasientene i den første gruppen vil også bli bedt om et intervju senere i 
studien, og det kan hende at du er blant dem som vil bli spurt. Intervjuet, som varer ca 1 
time, vil blant annet omhandle hvilket behov du har for informasjon, i hvilken grad 
WebChoice har møtt dine behov, samt din opplevelse av programmets nytte og 
brukervennlighet. Om du ikke ønsker å delta i er slikt intervju kan du likevel være med i 
studien. 
Hvis du blir trukket ut til å tilhøre den andre gruppen vil vi sende deg noen adresser til 
kvalitetssikrede, sykdomsrelevante nettsider. Ellers vil du få de samme spørreskjemaene 
som den første gruppen.    
 
Svarene dine fra spørreskjemaet, evt. intervju og informasjonen du utveksler via WebChoice 
vil bli behandlet strengt konfidensielt, og vil ikke bli utlevert til andre. Som bruker av 
WebChoice vil du få et eget brukernavn som er forskjellig fra ditt eget. All informasjon som 
utveksles er uten personidentifikasjon og beskyttet gjennom strenge datatekniske 
sikkerhetstiltak. Informasjon du utveksler vil bli kryptert (ingen andre kan lese det, eller 
gjenkjenne deg) og liggende i et lukket system ved Rikshospitalet-Radiumhospitalet HF. 
Utfylte skjema vil bli oppbevart i et låst arkivskap på prosjektleders kontor. Alle opplysninger 
som samles inn får en tallkode og er ikke knyttet til navn.  
 
Vi vil analysere data fra spørreskjema, fra systemloggen som forteller oss om hyppighet, 
varighet og hvilke deler i WebChoice som blir mest brukt, meldinger til og fra kreftsykepleier 
og innlegg i diskusjonsforum, og fra intervjuer med brukerne. Alle data vil bli avidentifisert, og 
ingen svar vil kunne tilbakeføres til deg som person når resultater under analysen eller 
senere av studien skal presenteres. Studien er tilrådd av Regional etisk komité for medisinsk 
forskningsetikk og Datatilsynet.   
 
 
 Deltakelse i studien medfører ingen kostnader for deg og du får ingen betaling for å delta. 
Det er ingen risiko forbundet med denne studien, men kanskje du vil synes at det er slitsomt 
å fylle ut spørreskjema. Vi vil gjøre vårt ytterste for å redusere denne ulempen. Kunnskapen 
som fremkommer av studien kan hjelpe kreftpasienter til å få en lettere hverdag. Studien vil 
gi helsearbeidere økte kunnskaper om kreftpasienters problemer/symptomer samt hvilket 
informasjonsbehov de har. Videre kan studien være med på å gi helsevesenet et redskap 
som kan sikre pasienter individuell oppfølging, informasjon og støtte på vei mot et mer 
pasientvennlig helsevesen. 
 
Selv om du sier ja til å delta i studien nå, kan du trekke deg fra studien når du måtte ønske 
det, uten å oppgi noen grunn, og uten at det vil ha noen konsekvenser. Dine data vil da bli 
slettet. 
 
Rikshospitalet-Radiumhospitalet HF er ansvarlig for å ivareta sikkerheten til 
personopplysninger som behandles i studien og databehandlingsansvarlig. Formålet med 
behandlingen i WebChoice er å legge til rette for oppfølging av deg som pasient mellom 
sykehusopphold.  Rikshospitalet-Radiumhospitalet HF vil behandle opplysningene i samsvar 
med gjeldende lovverk. 
 
WebChoice vil ha en brukerdatabase som inneholder ditt navn, personnummer og adresse 
som er hentet fra Folkeregisteret. Persondata som navn, adresse, mobiltelefon og e-
postadresse vil ikke utleveres til utenforstående. Du har rett til innsyn i de opplysninger 
WebChoice har om deg.  Bruk av løsningen er frivillig, og dette samtykket er en betingelse 
for å få tilgang til tjenesten.    
 
Vi regner med at studien i sin helhet vil være avsluttet etter 2008. Alle data vil være slettet 
senest etter 10 år, dvs. før 31.12.2015. 
 
Om du har spørsmål om deltakelse eller selve studien kan du ringe prosjektleder Dr. Cornelia 
M. Ruland ved Senter for sykepleieforskning og pasientmedvirkning på telefon 23 07 54 60.  
 
Om du ønsker å delta i studien ber vi deg signere siste siden på dette ”Informert samtykke” 
skjema, fylle ut vedlagte spørreskjema og sende det tilbake til oss i vedlagte konvolutt.  
Dersom du ikke ønsker å delta, kan du se bort fra denne henvendelsen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Informert samtykke 
 
 
Jeg samtykker i å være med i studien slik den er beskrevet ovenfor. Jeg er informert om at 
min deltakelse i studien er helt frivillig. Selv om jeg sier ja til å delta i dag, kan jeg trekke meg 
fra studien eller avbryte intervjuene når jeg måtte ønske det, og uten at det vil ha 
konsekvenser for min nåværende eller fremtidige behandling ved sykehuset. 
 
Dato:________ 
 
 
         
Navn: (blokkbokstaver): 
 
 
         
Signatur 
 
Jeg er også villig til å bli forespurt om å delta i et intervju, enten hjemme hos meg selv, eller ved 
Rikshospitalet-Radiumhospitalet. I så fall vil mine reiseutgifter bli dekket.  
    JA___ 

NEI___   
 
Hvis du vil delta i studien fyller du ut og signerer svarslippen, river ut siden og legger den i den lille 
ferdigfrankerte konvolutten og sender det til Senter for pasientmedvirkning og sykepleieforskning.  
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Forespørsel om deltakelse i forskningsprosjektet 
Effekt av internettstøtte for kreftpasienter som en del av klinisk praksis 
(WebChoice 2.0). 
 
Bakgrunn og hensikt 
Dette er en forespørsel til deg om å delta i et forskningsprosjekt for å teste ut effekten av et 
internettbasert støtteprogram som er utviklet for mennesker med kreft (WebChoice 2.0). Tilbudet er 
utviklet for støtte mellom og etter opphold ved sykehuset. WebChoice 2.0 har flere komponenter: 
mulighet til å nedtegne de problemer/plager man har, database med tiltak man iverksette mot disse 
plagene i hjemmesituasjonen, kvalitetssikrede internettlinker til informasjon om sykdom og 
behandling, diskusjonsforum med andre pasienter i samme situasjon, samt mulighet til å stille 
spørsmål via e-post i et sikkert system (spørsmål- og svartjeneste) til sykepleier ved sykehuset. Ved 
behov kan spørsmål videreformidles til lege eller sosionom ved sykehuset eller rådgiver hos 
Helseøkonomiforvaltningen (HELFO). Vi ønsker å undersøke om denne tjenesten eller deler av den 
kan hjelpe pasienter til å håndtere sykdommen og mestre hverdagen bedre. Vi vil også undersøke om 
bruk av tjenesten kan ha betydning for utgifter knyttet til sykdommen, samt behov for helse- og 
sosialtjenester fra det offentlige. 
 
Studien utgår fra Oslo universitetssykehus HF, Rikshospitalet. Du forespørres om å delta i studien 
fordi du er pasient ved et av våre samarbeidende sykehus.  
 
For å undersøke om denne internettjenesten er nyttig, vil studiedeltakerne bli inndelt i tre grupper; én 
gruppe som får tilgang til spørsmål- og svartjenesten, én gruppe som får tilgang til alle komponentene i 
WebChoice 2.0 og én sammenligningsgruppe som får det vanlige tjenestetilbudet fra sykehuset, uten 
disse spesielle tjenestene. Hvis du sier ja til å delta i studien, vil du bli tilfeldig trukket ut til å inngå i 
én av gruppene. 
 
Hva innebærer studien? 
Deltagelse i studien går over 18 måneder, hvorav bare de første 12 månedene fordrer noen aktivitet fra 
din side. Dersom du blir trukket ut til å være med i gruppen som får tilbud om å bruke spørsmål- og 
svartjenesten eller hele WebChoice 2.0, innebærer det at du i 12 måneder vil kunne benytte deg av 
tjenesten så mye du ønsker. Som bruker av tjenesten logger du deg på slik du logger deg på din 
nettbank. Dette vil du få nærmere forklaring på. All informasjon som utveksles er beskyttet gjennom 
strenge datatekniske sikkerhetstiltak og vil bli kryptert og liggende i et sikkert system ved Oslo 
universitetssykehus HF, Rikshospitalet. 
Enten du kommer i den gruppen som får tilgang til spørsmål- og svartjenesten, WebChoice 2.0 eller 
sammenligningsgruppen, vil vi be deg fylle ut noen opplysninger om deg selv på spørreskjemaer ved 
oppstart. Vi vil så sende deg spørreskjemaer etter 2, 4, 6, 8 og 12 måneder, som inneholder spørsmål 
om hvordan du har det i forbindelse med sykdom og behandling. Disse vil du bli bedt om å returnere 
til oss i en vedlagt ferdigfrankert konvolutt. Det vil ta ca ½ time å fylle ut skjemaene. Dersom du 
kommer i den gruppen som får tilbud om å bruke WebChoice 2.0 eller spørsmål- og svartjenesten vil 
du tillegg motta spørreskjema som omhandler hvor nyttig og brukervennlig du opplevde tjenestene.  
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I tillegg til data som samles inn gjennom spørreskjema ber vi om din tillatelse til å innhente følgende: 
 Data for hvordan du benytter tjenestene (hva som benyttes, hvor ofte, hvor lenge, innhold i 
meldinger, notater og kommunikasjon med andre pasienter). 
 Opplysninger fra offentlige registre (se utdyping under avsnittet om personvern) 12 og 18 
måneder etter din oppstart i studien om offentlige ytelser forbundet med sykdommen og bruk 
av helse- og sosialtjenester, evt. sykehusinnleggelser i aktuelle periode, samt ytelser til 
reseptbelagte legemidler. 
 Enkelte opplysninger om nåværende sykdom og behandling fra din journal ved sykehuset.  
 
Om du ikke ønsker å delta i denne studien, vil du motta vanlig behandlingstilbud ved den avdelingen 
du behandles ved. 
 
Mulige fordeler og ulemper 
Studien medfører ingen kostnader for deg og det er ingen risiko forbundet med studien. Gjennom din 
deltakelse vil du, enten du deltar i en av de to gruppene som prøver ut tjenestene eller i 
sammenligningsgruppen, bidra til viktig kunnskap om hvordan et tilpasset program for internettstøtte 
kan være til hjelp for mennesker med alvorlig sykdom. 
 
Fordeler for deg, dersom du blir trukket ut til å være med i den gruppen som får tilgang til spørsmål- 
og svartjenesten, vil være at du får mulighet til å benytte tjenesten etter og mellom sykehusopphold. 
Du kan stille spørsmål via elektroniske meldinger og få råd og veiledning fra sykepleier, og ved behov 
kan dine spørsmål videreformidles til lege og sosionom ved sykehuset eller rådgiver ved HELFO. De 
som besvarer meldingene fra deg har spesialkunnskap om din sykdom og behandling. Rådgivere ved 
HELFO vil få videreformidlet aktuelle spørsmål i anonymisert form fra sykepleier som betjener 
spørsmål- og svartjenesten. Dersom du blir trukket ut til gruppen som får tilgang til WebChoice 2.0 vil 
du i tillegg få tilgang til kvalitetssikret informasjon om tiltak som du kan iverksette selv mot 
sykdomsrelaterte plager. Du vil også få mulighet til å registrere egne plager, for eksempel som 
forberedelse til legebesøk, og mulighet til å kommunisere med mennesker i samme situasjon. Å kunne 
stille spørsmål og få svar fra fagpersoner uansett hvor du oppholder deg, samt ha tilgang til 
kvalitetssikret informasjon om sykdommen kan kanskje hjelpe deg å håndtere sykdommen og 
eventuelle komplikasjoner bedre når du er hjemme. 
 
Det er få ulemper og ubehag knyttet til deltakelse i studien. Noen vil kanskje oppleve det som slitsomt 
å svare på spørreskjemaer.  
 
Hva skjer med informasjonen om deg? 
Informasjonen som registreres om deg skal kun brukes slik som beskrevet i hensikten med studien. 
Alle opplysningene vil bli behandlet uten navn og fødselsnummer eller andre direkte gjenkjennende 
opplysninger. En kode (studie-ID) knytter deg til dine opplysninger gjennom en navneliste. 
Navnelisten er atskilt fra alle opplysninger vi samler om studiedeltakerne. Det er kun autorisert 
personell knyttet til prosjektet som har adgang til navnelisten og som kan finne tilbake til deg. Hvis det 
kommer frem noe i korrespondansen i spørsmål- og svartjenesten som er viktig for din behandling ved 
sykehuset, vil dette bli dokumentert i pasientjournalen.  
Det er innhentet nødvendig konsesjon fra Datatilsynet for å kunne sammenstille opplysninger fra 
NAV, HELFO, Norsk Pasientregister og Reseptregisterets databaser med studieopplysninger. All 
informasjon om deg vil slettes etter at studien er avsluttet, senest 31.12.2025.  
Det vil ikke være mulig å identifisere deg i resultatene av studien når disse publiseres. Studien er 
godkjent av Regional Etisk Komité (REK) Sør-Øst, Protokollutvalget og Personvernombudet ved Oslo 
universitetssykehus HF, Rikshospitalet.  
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Frivillig deltakelse 
Det er frivillig å delta i studien. Du kan når som helst og uten å oppgi noen grunn trekke ditt samtykke 
til å delta i studien. Dette vil ikke få konsekvenser for din videre behandling. Dersom du ønsker å 
delta, undertegner du samtykkeerklæringen på siste side. Om du nå sier ja til å delta, kan du senere 
trekke deg fra studien uten at det påvirker din øvrige behandling. Du kan i så fall også be om at de 
opplysninger vi allerede har fått fra deg blir slettet.  
 
Dersom du har spørsmål om studien, kan du kontakte prosjektleder Cornelia Ruland, tlf 23 07 54 60, 
stipendiat Elin Børøsund, tlf 23 07 54 52 eller studiesykepleier Kristin Iren Jensen, 77 66 92 12. 
 
 
Kapittel A- utdypende forklaring av hva studien innebærer 
 
Bakgrunnsinformasjon om studien: 
Mennesker med alvorlig sykdom kan oppleve mange problemer og bekymringer. Når de er hjemme 
mellom eller etter behandling er det ofte begrenset tilgang til profesjonell hjelp. Internettbaserte 
tjenester har vist seg å være nyttige i forhold til å støtte pasienter til å mestre daglige utfordringer og 
behov. Derfor vil vi undersøke i hvilken grad WebChoice 2.0 eller kun en spørsmål– og svartjeneste 
kan hjelpe pasienter i en slik situasjon, med tanke på å ha det bedre gjennom sykdom og behandling, 
med mindre symptomer/plager og bekymringer, og bedre livskvalitet. Når en kan få hjelp umiddelbart 
når problemer oppstår, kan dette kanskje også bidra til raskere rehabilitering, forhindre 
komplikasjoner, styrke egenkompetanse, redusere medikamentbruk og å kunne komme raskere tilbake 
i arbeid.  
 
 Hvis denne studien viser at det er nyttig for deltakerne, vil det i framtiden være aktuelt å utvikle 
tilsvarende tjenester som kanskje kan bli en del av det ordinære tjenestetilbudet til pasienter med 
alvorlig sykdom. 
 
Kriterier for å delta i studien er at du er over 18 år, behersker norsk skriftlig og muntlig, har tilgang til 
internett og bruker nettbank med BankID som påloggingsnøkkel. 
 
Kapittel B - Personvern, økonomi og forsikring 
 
Personvern 
Data som vil bli registrert om deg den tiden du deltar i studien er:  
 opplysninger innhentet gjennom spørreskjema 
 kommunikasjon med helsepersonell i spørsmål- og svartjenesten  
 bruk av spørsmål- og svartjenesten og de ulike delene i WebChoice 2.0 (fra systemlogg)    
 opplysninger om nåværende sykdom og behandling fra pasientjournalen  
 sykefravær og ytelser til, rehabilitering, attføring eller uføretrygd (fra NAV)  
 besøk hos fastlege, spesialist, fysioterapeut eller bruk av dietetiske næringsmidler (fra HELFO)  
 sykehusopphold i form av poliklinikkbesøk eller innleggelser (Norsk Pasientregister)  
 utgifter til legemidler relatert til smerter, angst, depresjon og søvn (Reseptregisteret) 
 
Det foreligger konsesjon fra Regional etisk komité for dette og databehandlerkontrakt vil bli utarbeidet 
før innhenting av data fra eksterne registre. Opplysningene fra NAV, HELFO og Norsk Pasientregister 
innhentes fra deres respektive databaser av personer som har tjenestemessig tilgang til disse 
databasene. De vil få tilsendt studiedeltakernes personnummer og deres studie-ID fra oss på en CD- 
ROM og henter ut de aktuelle opplysningene om studiedeltakerne fra sin database via 
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personnummeret. Når opplysningene returneres til oss på CD-ROM (enten med kurer eller som 
rekommandert sending), vil personnummer være slettet, og kun studie-ID knytter opplysningene til 
hver enkelt studiedeltaker. Ved ankomst til navngitt medlem av forskningsteamet lagres data 
umiddelbart på sikker server for forskning ved sykehuset, og CD-ROM destrueres.  
Norsk Pasientregister forvaltes av Helsedirektoratet og Reseptregisteret av Folkehelseinstituttet. Ved 
Reseptregisteret vil data bli innhentet ved at vi på tilsvarende måte overfører filer med personnummer 
og opplysninger fra studien som skal ses opp mot data fra Reseptregisteret. Filene vil bli videresendt til 
Statistisk sentralbyrå (SSB) for avidentifisering og påføring av pseudonyme personnummer tilsvarende 
de som brukes i Reseptregisteret. Når vi mottar datafilene fra Reseptregisteret og lagrer dem på vår 
sikre forskningsserver, vil dataene være knyttet til pseudonymnummer. Dataene fra Reseptregisteret 
vil på denne måten ikke kunne spores til hver enkelt studiedeltaker, men være fullstendig 
anonymiserte. 
Kun navngitte medlemmer av forskningsteamet vil der ha tilgang til dataene. De vil ikke være 
tilgjengelige for personell som kommuniserer med pasientene i WebChoice 2.0. Alle medlemmene av 
forskningsteamet har taushetsplikt.  
Oslo universitetssykehus HF, Rikshospitalet ved administrerende direktør er databehandlings-
ansvarlig. 
 
Rett til innsyn og sletting av opplysninger om deg 
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke opplysninger som er registrert om 
deg. Du har videre rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. Dersom du 
trekker deg fra studien, kan du kreve å få slettet innsamlede opplysninger, med mindre opplysningene 
allerede er inngått i analyser eller brukt i vitenskapelige publikasjoner.  
 
Økonomi og Helse Sør-Østs rolle 
Studien er finansiert gjennom forskningsmidler fra Helse Sør-Øst, og bekostes også av Oslo 
Universitetssykehus HF, Rikshospitalet, Universitetssykehuset i Nord-Norge HF, Tromsø, Sykehuset 
Vestfold HF, Tønsberg og Sørlandet sykehus HF, Kristiansand. Det er ingen interessekonflikter å 
melde. 
 
Forsikring 
Du er forsikret på samme måte som ved ordinære opphold/konsultasjoner ved sykehuset. 
 
 
Informasjon om utfallet av studien 
Som deltaker i studien har du rett til å få informasjon om utfallet/resultatet av studien.  
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 WebChoice 2.0 
     
 Reg. Nr:    
     
 Initialer:    
 
 
 
Samtykke til deltakelse i studien 
”Effekt av internettstøtte for kreftpasienter som en del av klinisk praksis” (WebChoice 2.0) 
 
 
 
 
Jeg er villig til å delta i studien: 
 
 
--------------------------------------------------------------------------------------(navn i blokkbokstaver) 
 
 
--------------------------------------------------------------------------------------- 
(Signert av prosjektdeltaker, dato) 
 
 
 
 
 
Jeg bekrefter å ha gitt informasjon om studien 
 
 
---------------------------------------------------------------------------------------------------------------- 
(Signert, rolle i studien, dato) 
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
Dine symptomer eller plager 
 
 
Her ber vi deg angi hvilke symptomer og plager du har eller har hatt i forbindelse med din 
sykdom i løpet av den siste uken. Slik gjør du dette:  
 
Vennligst les gjennom hvert symptom. Dersom du har hatt symptomet, markerer du hvor 
plagsomt det har vært i boksen til høyre under ’Hvis ja, hvor plagsomt?’ Sett ring rundt det 
tallet som passer best. Dersom du ikke har hatt symptomet, sett et kryss i kolonnen under 
’Nei’ (ikke hatt symptomet) og gå videre til neste. 
 
Se eksempel: Dersom du ikke har hatt smerter, men har vært plaget en del med lite energi, 
ville du fylt ut spørsmålene som vist nedenfor. 
 
 
 
Har du hatt noen av følgende symptomer eller 
plager den siste uken? 
 
 
 
   Nei 
(ikke hatt 
symptomet) 
Hvis ja, hvor plagsomt? 
 Ik
ke
 
Li
tt 
En
 d
el
 
   
M
ye
 
 S
væ
rt 
m
ye
 
Smerter       X 0 1   2 2 4 
Har lite energi  0 1   2 2 4 
 
 
 
 
Vennligst gå til neste side for å begynne! 
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Har du hatt noen av følgende 
symptomer eller plager den siste uken? 
 
 
 
   Nei 
(ikke hatt 
symptomet) 
Hvis ja, hvor plagsomt? 
   
Ik
ke
 
Li
tt 
En
 d
el
 
 M
ye
 
 S
væ
rt
 m
ye
 
1. Vanskelig å konsentrere meg  0 1 2 3 4 
2. Smerter  0 1 2 3 4 
3. Har lite energi  0 1 2 3 4 
4. Hoste  0 1 2 3 4 
5. Føler meg nervøs  0 1 2 3 4 
6. Tørr i munnen  0 1 2 3 4 
7. Kvalme  0 1 2 3 4 
8. Søvnig, mye trett  0 1 2 3 4 
9. Nummen/prikker i hender/føtter  0 1 2 3 4 
10. Søvnvansker  0 1 2 3 4 
11. Luft i magen/ oppblåst  0 1 2 3 4 
12. Problemer med vannlating  0 1 2 3 4 
13. Kaster opp  0 1 2 3 4 
14. Kortpustet  0 1 2 3 4 
15. Diaré  0 1 2 3 4 
16. Føler meg trist  0 1 2 3 4 
17. Svette  0 1 2 3 4 
18. Bekymrer meg  0 1 2 3 4 
19. Problemer med seksuallyst/seksuell aktivitet  0 1 2 3 4 
20. Kløe  0 1 2 3 4 
21. Manglende matlyst  0 1 2 3 4 
22. Svimmel/ør i hodet  0 1 2 3 4 
23. Vanskelig å svelge  0 1 2 3 4 
24. Føler meg irritabel  0 1 2 3 4 
25. Sår i munnen  0 1 2 3 4 
26. Maten smaker annerledes  0 1 2 3 4 
27. Vekttap  0 1 2 3 4 
28. Mistet håret  0 1 2 3 4 
29. Treg mage/forstoppelse  0 1 2 3 4 
30. Hoven i armer og ben  0 1 2 3 4 
31. ”Jeg ser ikke ut som meg lengre”  0 1 2 3 4 
32. Forandringer i huden  0 1 2 3 4 
 
 
 
 
 
 
 
 
ID: ___________  Dato: _____________ 
 
 
Om å håndtere kreftsykdom 
 
Hvor trygg føler du deg på at du vil håndtere din kreftsykdom? Sett en ring rundt det 
tallet på linjen som passer best for deg. 
 
 
 
Jeg føler meg trygg på at jeg klarer å: 
 
 
1. Beholde min uavhengighet                   1        2        3        4        5        6        7        8____9          
                                                                                Absolutt ikke                                         Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
 
 
 
2. Beholde en positiv holdning                 1        2        3        4        5        6        7        8        9   
                                                    Absolutt ikke                                         Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                           trygg 
 
 
 
3. Akseptere at jeg har kreft                      1        2        3        4        5        6        7        8        9   
                                                    Absolutt ikke                                          Ganske                                                      Helt 
                                                                                trygg                                                        trygg                                                         trygg 
 
 
 
 
4. Fortsette å arbeide                                 1        2        3        4        5        6        7        8        9   
                                                    Absolutt ikke                                          Ganske                                                       Helt 
                                                                                trygg                                                       trygg                                                           trygg 
 
 
 
 
5. Stille sykepleierne spørsmål                  1        2        3        4        5        6        7        8        9   
                                                    Absolutt ikke                                         Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
 
6. Beholde roen gjennom  
    behandlingen og ikke la  
    skremmende tanker gjøre 
    meg bekymret                                     1        2        3        4        5        6        7        8       9                                                
                                                    Absolutt ikke                                         Ganske                                                        Helt 
                                                                                               trygg                                                      trygg                                                           trygg 
 
 
 
7. Søke støtte fra andre utenom  
    familien                                                  1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                  trygg                                                      trygg                                                          trygg 
 
 
 
8. Opprettholde en daglig rutine                1        2        3        4        5        6        7        8       9   
                                                                                Absolutt ikke                                         Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
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Jeg føler meg trygg på at jeg klarer å: 
 
 
9. Stille spørsmål til annet helsepersonell 
   (stråleterapeuter, bioingeniører etc)           1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
 
 
 
10. Mestre håravfall                                      
                                                                   1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
 
 
11. Skyve bekymringer omkring  
      sykdommen i bakgrunnen                    1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                  trygg                                                     trygg                                                          trygg 
 
 
12. Beholde roen  
      gjennom behandlingen                         1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                  trygg                                                     tygg                                                            trygg 
 
 
 
             
13. Mestre fysiske forandringer                 1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                           trygg 
             
 
 
14. Ignorere ting som ikke kan 
      håndteres i øyeblikket                          1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                       trygg                                                          trygg 
 
 
 
15. Delta aktivt i bestemmelser  
     om min behandling                                1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
 
 
 
16. Dele bekymringer med andre               1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                        Helt 
                                                                                 trygg                                                      trygg                                                           trrygg 
 
 
17. Beholde roen selv om jeg må                
     vente minst 1 time på legeavtalen  
     min                                                        1        2        3        4        5        6        7        8      9   
                                                                                               Absolutt ikke                                         Ganske                                                       Helt 
                                                                                  trygg                                                     trygg                                                           trygg 
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Jeg føler meg trygg på at jeg klarer å: 
 
 
18. Gi uttrykk for personlige  
      følelser som sinne eller motvilje          1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                           trygg 
 
 
19. Søke informasjon om kreft  
      eller kreftbehandling                            1        2        3        4        5        6        7        8       9   
                                                    Absolutt ikke                                         Ganske                                                        Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
 
 
20. Gi uttrykk for negative følelser 
      i forhold til kreftsykdommen               1        2        3        4        5        6        7        8       9  
                                                    Absolutt ikke                                         Ganske                                                       Helt 
                                                                                trygg                                                       trygg                                                          trygg 
 
 
                                                
21. Holde meg opptatt med aktiviteter       1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
                                                      
 
 
22. Finne en utvei                                       1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                           trygg 
                                                       
 
23. Redusere angst knyttet til  
      å ta blodprøve                                       1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
                                                
 
 
24. Beholde humoristisk sans                     1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                           trygg 
 
25. Akseptere fysiske forandringer         
      eller begrensninger oppstått 
      pga kreftbehandling                              1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
 
 
 
 
26. Søke trøst                                              1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
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Jeg føler meg trygg på at jeg klarer å: 
 
 
 
27. Redusere kvalme i forbindelse 
      med behandling                                    1        2        3        4        5        6        7        8       9   
                                                    Absolutt ikke                                         Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg 
 
 
 
 
 
28. Opprettholde håp                                  1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                 trygg                                                      trygg                                                          trygg                             
 
 
 
29. Stille leger spørsmål                             1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                  trygg                                                     trygg                                                          trygg 
 
 
 
 
 
30. Gjøre noe, hva som helst                     1        2        3        4        5        6        7        8        9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                  trygg                                                     trygg                                                          trygg 
 
 
 
 
 
31. Håndtere smerte                                   1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                  trygg                                                     trygg                                                          trygg 
 
 
 
32. Håndtere kvalme                    
      og brekninger                                       1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                       Helt 
                                                                                  trygg                                                     trygg                                                           trygg 
 
33. Ha kontroll over de negative  
      følelsene i forbindelse med 
      kreften                                                  1        2        3        4        5        6        7        8       9   
                                                     Absolutt ikke                                        Ganske                                                      Helt 
                                                                                  trygg                                                     trygg                                                          trygg 
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Livskvalitet 
 
(New 15D/Harri Sintonen) 
 
Vennligst les gjennom alle svaralternativene til hvert spørsmål før du plasserer et kryss (x) for 
det alternativet som best beskriver din nåværende tilstand. Fortsett på samme måte for alle 15 
spørsmålene. Gi bare ett svar på hvert spørsmål. 
 
 
1. BEVEGELIGHET 
1  Jeg er i stand til å gå normalt (uten vanskelighet) innendørs, utendørs og i trapper 
2  Jeg er i stand til å gå uten vanskelighet innendørs, men utendørs og/eller i trapper har jeg litt 
        problemer 
3 Jeg er i stand til å gå uten hjelp innendørs (med eller uten hjelpemiddel), men utendørs og/eller 
        i trapper bare med betydelig vanskelighet eller med hjelp fra andre 
4  Jeg er i stand til å gå innendørs kun med hjelp fra andre 
5  Jeg er fullstendig sengeliggende og ute av stand til å bevege meg omkring 
 
 
2. SYN 
1  Jeg ser normalt, dvs. jeg kan lese aviser og tekst på TV uten vanskelighet (med el. uten briller) 
2  Jeg kan lese aviser og/eller tekst på TV med litt vansker (med eller uten briller) 
3  Jeg kan lese aviser og/eller tekst på TV med betydelige vansker (med eller uten briller) 
4  Jeg kan ikke lese aviser og/eller tekst på TV verken med briller eller uten, men jeg kan se godt  
         nok til å gå omkring uten hjelp 
5  Jeg kan ikke se godt nok til å gå omkring uten hjelp, dvs. jeg er nesten eller helt blind 
 
 
3. HØRSEL 
1  Jeg hører normalt, dvs. normal tale (med eller uten høreapparat) 
2  Jeg hører normal tale med litt vansker 
3  Jeg hører normal tale med betydelige vansker; i samtaler må stemmer være høyere enn normalt 
4  Jeg hører selv sterke stemmer dårlig; jeg er nesten døv 
5  Jeg er helt døv 
 
 
4. PUST 
1  Jeg er i stand til å puste normalt, dvs. uten å være kortpustet eller ha andre pustevansker 
2  Jeg er kortpustet under tungt arbeid eller sport, eller når jeg går raskt på flat mark eller i slak 
         motbakke 
3  Jeg er kortpustet når jeg går på flat mark med samme tempo som andre på min alder 
4  Jeg blir kortpustet selv etter lett aktivitet, f.eks. når jeg vasker meg eller kler på meg 
5  Jeg har pustevansker nesten hele tiden, selv i hvile 
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5. SØVN 
1  Jeg er i stand til å sove normalt, dvs. jeg har ingen problem med å sove 
2  Jeg har lette søvnproblemer, f.eks. vanskelig for å falle i søvn eller våkner av og til om natten 
3  Jeg har moderate søvnproblemer, f.eks. forstyrret søvn eller føler at jeg ikke har sovet nok 
4  Jeg har store søvnproblemer, f.eks. må bruke sovemedisiner ofte eller rutinemessig, eller våkner  
         om natten og/eller for tidlig om morgenen 
5  Jeg lider av alvorlig søvnløshet, f.eks. er søvn nesten umulig selv med bruk av sovemedisiner,  
         eller jeg forblir våken det meste av natten 
 
 
6. SPISING 
1  Jeg er i stand til å spise normalt, dvs. uten hjelp fra andre 
2  Jeg er i stand til å spise selv med mindre vansker (f.eks. langsomt, klønete, skjelvende eller med  
         spesielle hjelpemidler) 
3  Jeg trenger noe hjelp fra en annen person for å spise 
4  Jeg er ute av stand til å spise selv i det hele tatt, slik at jeg må mates av en annen person 
5  Jeg er ute av stand til å spise i det hele tatt, slik at jeg mates enten med slange eller intravenøst 
 
 
7. TALE 
1  Jeg er i stand til å tale normalt, dvs. klart, hørbart og flytende 
2  Jeg har lette vansker med å snakke, f.eks. famler av og til etter ord, mumler eller endrer  
         stemmeleiet 
3  Jeg kan gjøre meg forstått, men min tale er f.eks. oppstykket, nølende, stotrende eller 
        stammende 
4  De fleste mennesker har store vansker med å forstå hva jeg sier 
5  Jeg kan bare gjøre meg forstått med fakter 
 
 
8. VANNLATING / AVFØRING 
1  Min blære og tarm fungerer normalt og uten problemer 
2  Jeg har lette problemer med min blære- og/eller tarmfunksjon, f.eks. vansker med å urinere eller  
         løs eller hard avføring 
3  Jeg har betydelige problemer med min blære- og/eller tarmfunksjon, f.eks. ”uhell” av og til, eller  
         alvorlig forstoppelse eller diaré 
4  Jeg har alvorlige problemer med min blære- og/eller tarmfunksjon, f.eks. regelmessige ”uhell”,  
         eller behov for kateterisering eller klyster  
5  Jeg har ikke kontroll over min blære- og/eller tarmfunksjon 
 
 
 
 
 
ID: ___________  Dato: _____________ 
9. VANLIGE AKTIVITETER 
1  Jeg er i stand til å utføre mine vanlige aktiviteter (f.eks. arbeid, studier, husarbeid,  
         fritidsaktiviteter) uten vanskelighet 
2  Jeg er i stand til å utføre mine vanlige aktiviteter noe mindre effektivt eller med litt vanskelighet 
3  Jeg er i stand til å utføre mine vanlige aktiviteter mye mindre effektivt, med betydelig  
         vanskelighet, eller ikke fullt ut 
4  Jeg kan bare klare en liten del av mine vanlige aktiviteter fra tidligere 
5  Jeg er ute av stand til å klare noen av mine vanlige aktiviteter fra tidligere 
 
 
10. MENTAL FUNKSJON 
1  Jeg er i stand til å tenke klart og logisk, og min hukommelse fungerer godt 
2  Jeg har litt vansker med å tenke klart og logisk, eller min hukommelse svikter meg av og til 
3  Jeg har merkbare vansker med å tenke klart og logisk, eller min hukommelse er noe redusert 
4  Jeg har store vansker med å tenke klart og logisk, eller min hukommelse er betydelig nedsatt 
5  Jeg er stadig forvirret eller desorientert for sted og tid 
 
 
11. UBEHAG OG SYMPTOMER 
1  Jeg har ikke fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc. 
2  Jeg har lett fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc. 
3  Jeg har tydelig fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc. 
4  Jeg har alvorlig fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc. 
5  Jeg har uholdbart fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc. 
 
 
12. DEPRESJON 
1  Jeg føler meg overhodet ikke trist, melankolsk eller deprimert 
2  Jeg føler meg litt trist, melankolsk eller deprimert 
3  Jeg føler meg middels trist, melankolsk eller deprimert 
4  Jeg føler meg svært trist, melankolsk eller deprimert 
5  Jeg føler meg ekstremt trist, melankolsk eller deprimert 
  
 
13. STRESS 
1  Jeg føler meg overhodet ikke engstelig, stresset eller nervøs 
2  Jeg føler meg litt engstelig, stresset eller nervøs 
3  Jeg føler meg middels engstelig, stresset eller nervøs  
4  Jeg føler meg svært engstelig, stresset eller nervøs 
5  Jeg føler meg ekstremt engstelig, stresset eller nervøs  
 
 
ID: ___________  Dato: _____________ 
 
14. LIVSKRAFT 
1  Jeg føler meg frisk og energisk 
2  Jeg føler meg litt sliten, trett eller svak 
3  Jeg føler meg middels sliten, trett eller svak 
4  Jeg føler meg svært sliten, trett eller svak, nesten utslitt 
5  Jeg føler meg ekstremt sliten, trett eller svak, totalt utslitt 
 
 
15. SEKSUELL AKTIVITET 
1  Min helsetilstand har ingen ugunstig innvirkning på min seksuelle aktivitet 
2  Min helsetilstand har en liten innvirkning på min seksuelle aktivitet 
3  Min helsetilstand har en betydelig innvirkning på min seksuelle aktivitet 
4  Min helsetilstand gjør seksuell aktivitet nesten umulig 
5  Min helsetilstand gjør seksuell aktivitet umulig 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID: ___________  Dato: _____________ 
SOSIAL STØTTE 
 
Hvor ofte er hver av de nedenfor nevnte typer støtte tilgjengelig for deg når du trenger 
det?  
 
Kryss av ved det som passer best ved hvert 
spørsmål 
Aldri Enkelte 
ganger 
Av og til Meste 
parten 
av tiden 
Hele 
tiden 
1. Noen som hjelper deg når du må holde sengen 
 
     
2. Noen som du regner med vil høre på deg når du har 
    behov for å snakke 
     
3. Noen som gir deg gode råd i forbindelse med en 
    krise 
 
 
    
4. Noen som følger deg til legen når du har behov for 
    det 
 
 
    
5. Noen som gir deg kjærlighet og omsorg  
 
    
6. Noen som du har det hyggelig sammen med  
 
    
7. Noen som gir deg informasjon for å hjelpe deg til å 
forstå situasjonen/problemet 
     
8. Noen som du betror deg til, eller snakker med om 
    deg selv eller dine problemer 
     
9. Noen som gir deg en klem  
 
    
10. Noen som du slapper av sammen med  
 
    
11. Noen som lager mat til deg hvis du ikke kan gjøre 
      det selv 
     
12. Noen som gir deg råd du virkelig ønsker  
 
    
13. Noen å gjøre ting sammen med for å hjelpe deg til 
      å komme på andre tanker 
     
14. Noen som hjelper til med de daglige gjøremål hvis 
      du er syk 
     
15. Noen å dele dine mest private bekymringer og 
      redsler med 
 
 
    
16. Noen å henvende deg til for å få råd om hvordan 
      du kan håndtere et personlig problem 
     
17. Noen å gjøre noe hyggelig sammen med  
 
    
18. Noen som forstår dine problemer  
 
    
19. Noen å elske og som får deg til å føle deg ønsket  
 
    
 
ID: ___________  Dato: _____________ 
DEPRESJON 
 
 
Vennligst sett et kryss under det tallet som 
markerer hvor ofte du har følt det slik i løpet 
av den siste uken 
0 
Sjelden eller 
aldri 
(mindre enn 
en gang i 
uken) 
1 
Noen   
ganger 
(1-2 dager i 
uken) 
2 
Ofte 
(3-4 dager i 
uken) 
3 
For det 
meste/ hele 
tiden 
(5-7 dager i 
uken) 
1. Jeg ble plaget av ting som vanligvis ikke plager 
meg 
    
2. Jeg følte at alt jeg gjorde var en 
kraftanstrengelse  
    
3. Jeg følte at jeg var like bra som andre 
mennesker 
    
4. Jeg hadde problemer med å konsentrere meg 
om det jeg holdt på med 
    
5. Jeg følte meg trist 
 
    
6. Jeg følte meg redd 
 
    
7. Jeg følte meg ensom 
 
    
8. Jeg hadde gråtetokter 
 
    
9. Jeg snakket mindre enn vanlig 
 
    
10. Jeg sov urolig 
 
    
11. Jeg gledet meg over livet 
 
    
12. Jeg følte at jeg ikke ble kvitt det å være 
nedtrykt selv med hjelp fra familie/venner 
    
13. Jeg følte at livet mitt var mislykket 
 
    
14. Jeg var lykkelig 
 
    
15. Jeg hadde ikke noe initiativ 
 
    
16. Jeg følte meg optimistisk i forhold til 
fremtiden 
    
17. Folk var uvennlige 
 
    
18. Jeg hadde ikke lyst til å spise; matlysten var 
dårlig 
    
19. Jeg følte meg deprimert 
 
    
20. Jeg følte at folk mislikte meg 
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Initialer:
Reg. Nr:
Vennligst les hvert spørsmål nøye før du svarer.  Hvis du er usikker hva du skal svare på et spørsmål,
svar så godt du kan. Husk at det er ingen riktige eller gale svar.
Du kan oppleve at noen av spørsmålene overlapper hverandre.  Grunnen til dette er at vi bruker
standardiserte skjemaer som gjør det mulig å sammenligne resultatene fra denne studien med andre
studier.  Vi kan derfor ikke fjerne spørsmål fra disse skjemaene, og ber deg besvare alle, selv om du
kansje allerede har besvart de et annet sted i heftet.
Dine svar på dette spørreskjemaet vil bli behandlet strengt konfidensielt, og de vil bare bli brukt til
forskning.  Informasjonen du gir vil bli bearbeidet sammen med svarene fra andre pasienter som også
fyller ut skjemaet, slik at det ikke blir mulig å finne tilbake til svarene fra enkeltpersoner.
Utfylling av skjema:
1. Bruk bare blå eller sort kulepenn (ikke blyant)
2. Kryss innenfor rutene:
3. Skjemaet må ikke brettes (gir streker i skjemaet ved optisk lesing)
4. Skriv tydelig
X
DATO FOR UTFYLLING: . .
dag            måned                   år(Fylles ut av pasient)
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BAKGRUNNSOPPLYSNINGER
Vennligst sett kryss eller fyll inn det som passer:
1.   Sivilstatus: (Sett ett kryss)
Gift/samboer
Skilt/separert
Ugift
Enke/enkemann
2.   a) Hvor mange barn har du?
3.   Høyeste fullførte utdanning: (Sett ett kryss)
Grunnskole
Videregående skole
Universitet og/eller høgskole opptil 4 år
Universitet og/eller høgskole mer enn 4 år
b) Hvor mange barn bor du sammen med
(helt eller delvis)?
4.   Arbeid/studier per i dag: (Sett gjerne flere kryss)
Heltidsarbeid
Deltidsarbeid
Hjemmearbeidende
Studier
Uførepensjon
Alderspensjon
Arbeidsledig/permittert
Sykmeldt (helt)
Sykmeldt (delvis)
Rehabilitering/yrkesrettet attføring
Hvis annet, spesifiser:
5.   Husholdningens totale årsinntekt: (Sett ett kryss)
Under 200 000
200 000 - 399 999
400 000 - 599 999
600 000 - 799 999
800 000 - 1 000 000
Over 1 000 000
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1 2 3 4 5
Minst en
gang hver
hverdag
Sender e-post
Hvor ofte benytter du deg av følgende
tjenester på internett?
6.
Minst en
gang i uken,
men ikke
hver dag
Minst en
gang i
måneden, men
ikke hver uke
Mindre enn
en gang i
måneden
Aldri
Mottar e-post
Benytter banktjenester
Kjøper varer
Bestiller billetter
Spiller eller laster ned spill og/eller musikk
Leser eller laster ned nyhetssider
Leser eller laster ned fakta/bakgrunnsstoff
Leser eller laster ned helseinformasjon
Deltar i nettsamfunn
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
3 / 15
Reg. Nr:9012
2010_WebChoice_Baseline Kontor for Klinisk Forskning, Radiumhospitalet
TILLEGGSSYKDOMMER (SCQ-18)
Det følgende er en liste over vanlige medisinske problemer.  Sett ett kryss for hvert problem om hvorvidt du
har problemet nå (ja eller nei).  Hvis du HAR problemet, så svar på spørsmålene om behandling og aktiviteter til
høyre.  Hvis du IKKE HAR problemet, gå videre til neste problem.
1.   Hjertesykdom
2.   Høyt blodtrykk
3.   Lungesykdom
4.   Diabetes
5.   Magesår/magesykdom
6.   Tarmsykdom
7.   Nyresykdom
8.   Leversykdom
9.   Anemi eller annen blodsykdom
10.  Hodepine
11.  Depresjon
12.  Slitasjegikt/artrose
13.  Rygg/nakkesmerter
14.  Leddgikt/revmatoid artritt
15.  Sykdom i bindevev eller muskulatur
16.  Hudlidelser
17.  Andre medisinske problemer (angi)
   Har du
problemet?
HVIS JA:
Får du behandling
       for det?
      HVIS JA:
  Begrenser det
dine aktiviteter?Problem
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei
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SYMPTOMLISTE (MSAS)
Veiledning:  Vi har listet opp 32 symptomer nedenfor.  Les hvert av dem nøye.  Hvis du har hatt symptomet i løpet av
siste uken, la oss få vite hvor ofte du hadde det, hvor kraftig det var det meste av tiden, og hvor mye det plaget eller
bekymret deg, ved å sette ett kryss i den ruten du synes passer best.  Hvis du IKKE HAR HATT symptomet, sett ett
kryss i den ruten merket HAR IKKE HATT symptomet.
Vanskelig å konsentrere seg
Smerter
Har lite energi
Hoste
Føler meg nervøs
Tørr i munnen
Kvalme
Søvnig, mye trøtt
Nummen/prikker i hender/føtter
Søvnvansker
Luft i magen/oppblåst
Problemer med vannlating
Kaster opp
Kortpustet
Diaré
Føler meg trist
Svette
Bekymrer meg
Problemer med seksuallyst/
aktivitet
I løpet av den
siste uken:
Har du hatt noen
av de følgende
symptomene?
      Hvis JA:
Hvor ofte hadde
du symptomet?
      Hvis JA:
Hvor kraftig var
symptomet, det
meste av tiden?
     Hvis JA:
Hvor mye plaget
eller bekymret
symptomet deg?
Svæ
rt mye 
Ganske mye 
En del 
Litt 
Ikke i det 
hele tatt 
Svæ
rt  
kraftig 
Kraftig 
Moderat 
Svakt 
Nesten  
hele tiden 
Ofte 
Av og til 
Sjelden 
H
ar ikke hatt sym
ptom
et
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SYMPTOMLISTE (MSAS) - del 2
Kløe
Manglende matlyst
Svimmel/ør
Vanskelig å svelge
Føler meg irritabel
Sår i munnen
Maten smaker annerledes
Vekttap
Mistet håret
Treg mage/forstoppelse
Hoven i armer og ben
"Jeg ser ikke ut som meg
 selv lengre"
Forandringer i huden
I løpet av den siste
uken:
Har du hatt noen av
de følgende
symptomene?
 Hvis JA:
Hvor ofte hadde
du symptomet?
 Hvis JA:
Hvor kraftig var
symptomet, det
meste av tiden?
 Hvis JA:
Hvor mye plaget
eller bekymret
symptomet deg?
H
ar ikke hatt sym
ptom
et 
Hvis du har hatt noen andre symptomer i løpet av den siste uken, vennligst skriv de
opp nedenfor, og angi hvor mye det plaget eller bekymret deg.
Annet:
Annet:
Annet:
Svæ
rt mye 
Ganske mye 
En del 
Litt 
Ikke i det 
hele tatt 
Svæ
rt mye 
Ganske mye 
En del 
Litt 
Ikke i det 
hele tatt 
Svæ
rt  
kraftig 
Kraftig 
Moderat 
Svakt 
Nesten  
hele tiden 
Ofte 
Av og til 
Sjelden 
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OM HVORDAN DU FØLER DEG (HADS)
Disse spørsmålene er utformet for å hjelpe oss til å forstå hvordan du føler deg. Les hvert spørsmål og sett kryss
i boksen for det svar som best beskriver dine følelser den siste uken.
Ikke tenk for lenge på svaret - de spontane svarene er best.
2. Jeg gleder meg fremdeles over ting jeg pleide å glede
    meg over
 3. Jeg har en urofølelse som om noe forferdelig
     kommer til å skje
 4. Jeg kan le og se det morsomme i situasjoner
 5. Jeg har hodet fullt av bekymringer
 6. Jeg er i godt humør
 7. Jeg kan sitte i fred og ro og kjenne meg avslappet
 8. Jeg føler det som om alt går langsommere
 9. Jeg føler meg urolig liksom jeg har
     sommerfugler i magen
10. Jeg har sluttet å bry meg om hvordan jeg ser ut
11. Jeg er rastløs som om jeg stadig må være i aktivitet
12. Jeg ser med glede frem til hendelser og ting
13. Jeg kan plutselig få en følelse av panikk
14. Jeg kan glede meg over en god bok eller et radio-
eller TV- program
 1. Jeg er nervøs eller anspent
For det meste
Ofte
Noen ganger
Ikke i det hele tatt
Avgjort like mye
Ikke fullt så mye
Bare lite grann
Ikke i det hele tatt
Helt sikkert og svært ille
Ja, men ikke så veldig ille
Litt ille, men det bekymrer meg ikke så mye
Ikke i det hele tatt
Like mye som jeg alltid har gjort
Ikke like mye nå som før
Avgjort ikke så mye nå som før
Ikke i det hele tatt
Veldig ofte
Ganske ofte
Av og til
En gang i blant
Aldri
Noen ganger
Ganske ofte
For det meste
Ja, helt klart
Vanligvis
Ikke så ofte
Ikke i det hele tatt
Nesten hele tiden
Svært ofte
Fra tid til annen
Ikke i det hele tatt
Ikke i det hele tatt
Fra tid til annen
Ganske ofte
Svært ofte
Ja, helt klart
Jeg bryr meg ikke så mye som jeg burde
Det kan nok hende jeg ikke bryr meg nok
Jeg bryr meg om utseendet like mye som jeg
Uten tvil svært mye
Ganske mye
Ikke så veldig mye
Ikke i det hele tatt
Like mye som jeg alltid har gjort
Heller mindre enn jeg pleier
Avgjort mindre enn jeg pleier
Nesten ikke i det hele tatt
Uten tvil svært ofte
Svært ofte
Ikke så veldig ofte
Ikke i det hele tatt
Ofte
Fra tid til annen
Ikke så ofte
Svært sjelden
alltid har gjort
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1.   Beholde min uavhengighet
2.   Beholde en positiv holdning
3.   Akseptere at jeg har kreft
4.   Fortsette å arbeide
5.   Stille sykepleierne spørsmål
6.   Beholde roen gjennom behandlingen
og ikke la skremmende tanker gjøre
meg bekymret
7.   Søke støtte fra andre utenom
familien
8.   Opprettholde en daglig rutine
9.   Stille spørsmål til annet
helsepersonell (stråleterapeuter,
bioingeniører osv.)
10.  Mestre håravfall
11.  Skyve bekymringer omkring
 sykdommen i bakgrunnen
12.  Beholde roen gjennom
 behandlingen
13.  Mestre fysiske forandringer
14.  Ignorere ting som ikke kan 
 håndteres i øyeblikket
15.  Delta aktivt i beslutninger om min      
 behandling
16.  Dele bekymringer med andre
1 2 3 4 5 6 7 8 9
Absolutt ikke
      trygg
Ganske
  trygg
 Helt
trygg
OM Å HÅNDTERE KREFTSYKDOM (CBI)
Hvor trygg føler du deg på at du vil håndtere din kreftsykdom? Vennligst sett ett kryss i den ruten som
passer best for deg (ett kryss for hvert spørsmål).
Jeg føler meg trygg på at jeg klarer å:
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
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17.  Beholde roen selv om jeg må vente
 minst 1 time på legeavtalen min
18.  Gi uttrykk for personlige følelser
som sinne eller motvilje
19.  Søke informasjon om kreft eller
 kreftbehandling
20.  Gi uttrykk for negative følelser i
 forhold til kreftsykdommen
21.  Holde meg opptatt med aktiviteter
22.  Finne en utvei
23.  Redusere engstelse knyttet til å ta
 blodprøve
24.  Beholde humoristisk sans
25.  Akseptere fysiske forandringer eller
 begrensninger oppstått pga
 kreftbehandling
26.  Søke trøst
27.  Redusere kvalme i forbindelse med
 behandling
28.  Opprettholde håp
29.  Stille leger spørsmål
30.  Gjøre noe, hva som helst
31.  Håndtere smerte
32.  Håndtere kvalme og brekninger
33.  Ha kontroll over de negative 
 følelsene i forbindelse med kreften
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
Absolutt ikke
      trygg
Ganske
  trygg
 Helt
trygg
Jeg føler meg trygg på at jeg klarer å:
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
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OM USIKKERHET MAN KAN OPPLEVE VED SYKDOM (MUIS)
Dette spørreskjemaet er laget for å få vite noe om den usikkerheten man kan oppleve når man er syk.
Vennligst les hver påstand nøye. Svar på hver påstand ved å sette et kryss for det svaralternativet som
passer best for hvordan du har det i dag. Hvis du er enig i en påstand, kan du krysse av for "helt enig" eller
"enig". Er du uenig i en påstand, kan du krysse av for "helt uenig" eller "uenig". Hvis du er usikker på
hvordan du har det, så kryss av for "usikker". Det er ikke noe svar som er "riktig" eller "galt".
1 2 3 4 5
Helt
enig
 Enig Usikker Uenig Helt
uenig
 1. Jeg vet ikke hva som feiler meg
2. Jeg har mange ubesvarte spørsmål 1 2 3 4 5
3. Jeg er usikker på om sykdommen min blir
bedre eller verre 1 2 3 4 5
4. Det er uklart hvor ille smertene mine
vil bli 1 2 3 4 5
5. Forklaringene som helsepersonell gir
om min tilstand virker uklare for meg 1 2 3 4 5
6. Jeg forstår hensikten med hver behandling 1 2 3 4 5
7. Når jeg har smerter vet jeg hva det vil si
om sykdomstilstanden min 1 2 3 4 5
8. Jeg vet ikke når jeg kan forvente at det
skal gjøres noe med meg 1 2 3 4 5
9. Symptomene mine fortsetter å endre seg
uforutsigbart
1 2 3 4 5
10. Jeg forstår alt som forklares for meg 1 2 3 4 5
11. Legene sier ting til meg som kan ha
forskjellig betydning 1 2 3 4 5
12. Jeg kan forutsi hvor lenge sykdommen
min vil vare
1 2 3 4 5
13. Den behandlingen jeg får er så kompleks
at jeg ikke forstår den 1 2 3 4 5
 14. Det er vanskelig å vite om behandlingen 
 eller medisinene jeg får hjelper 1 2 3 4 5
15. Det er så mange forskjellige yrkesgrupper
       at det er vanskelig å vite hvem som er
       ansvarlig for hva
1 2 3 4 5
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1 2 3 4 5
Helt
enig
 Enig Usikker Uenig Helt
uenig
1 2 3 4 5
1 2 3 4 5
17. Sykdomstilstanden forandrer seg hele
tiden. Jeg har mine gode og dårlige dager
1 2 3 4 5
18. Jeg er usikker på hvordan jeg vil klare meg
når jeg forlater sykehuset
1 2 3 4 5
19. Jeg har fått mange forskjellige
synspunkter på hva som feiler meg
1 2 3 4 5
20. Det er uklart hva som vil skje med meg
1 2 3 4 5
21. Jeg vet vanligvis om jeg vil få en god
eller dårlig dag
1 2 3 4 5
22. Svarene på prøvene mine er ikke i
samsvar med hverandre
1 2 3 4 5
23. Virkningen av behandlingen er usikker
1 2 3 4 5
24. Det er vanskelig å fastslå hvor lang tid
det vil ta før jeg kan klare meg selv
1 2 3 4 5
25. Jeg kan generelt forutsi sykdomsforløpet
mitt
1 2 3 4 5
26. Hva jeg kan og ikke kan gjøre forandrer
seg som en følge av behandlingen
27. Jeg er sikker på at de ikke vil finne noe
annet galt med meg
28. Det er kjent at den behandlingen jeg får
pleier å hjelpe
29. De har ikke gitt meg noen bestemt diagnose
1 2 3 4 5
1 2 3 4 5
1 2 3 4 530. Mine fysiske plager er forutsigbare. Jeg vetnår de blir bedre eller verre
31. Jeg kan stole på at sykepleierne er der når
jeg trenger dem 1 2 3 4 5
1 2 3 4 5
16. Siden sykdommen min er så uforutsigbar,
er det vanskelig å planlegge for framtiden
32. Alvorlighetsgraden av sykdommen min er
fastslått
33. Legene og sykepleierne bruker et 
      alminnelig språk så jeg kan forstå hva de sier 1 2 3 4 5
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LIVSKVALITET (15D)
Vennligst les gjennom alle svaralternativene til hvert spørsmål før du plasserer et kryss (x) for det alternativet
som best beskriver din nåværende tilstand. Fortsett på samme måte for alle 15 spørsmålene. Gi bare ett svar
på hvert spørsmål.
1. BEVEGELIGHET
Jeg er i stand til å gå normalt (uten vanskelighet) innendørs, utendørs og i trapper
Jeg er i stand til å gå uten vanskelighet innendørs, men utendørs og/eller i trapper har jeg litt problemer
Jeg er i stand til å gå uten hjelp innendørs (med eller uten et hjelpemiddel), men utendørs og/eller i trapper bare
Jeg er i stand til å gå innendørs kun med hjelp fra andre
Jeg er fullstendig sengeliggende og ute av stand til å bevege meg omkring
2. SYN
Jeg ser normalt, dvs. jeg kan lese aviser og tekst på TV uten vanskelighet (med eller uten briller)
Jeg kan lese aviser og/eller tekst på TV med litt vansker (med eller uten briller)
Jeg kan lese aviser og/eller tekst på TV med betydelige vansker (med eller uten briller)
Jeg kan ikke lese aviser og/eller tekst på TV verken med briller eller uten, men jeg kan se godt nok til å gå
Jeg kan ikke se godt nok til å gå omkring uten hjelp, dvs. jeg er nesten eller helt blind
3. HØRSEL
Jeg hører normalt, dvs. hører normal tale (med eller uten høreapparat)
Jeg hører normal tale med litt vansker
Jeg hører normal tale med betydelige vansker; i samtaler må stemmer være høyere enn normalt
Jeg hører selv sterke stemmer dårlig; jeg er nesten døv
Jeg er helt døv
4. PUST
Jeg er i stand til å puste normalt, dvs. uten å være kortpustet eller ha andre pustevansker
Jeg er kortpustet under tungt arbeid eller sport, eller når jeg går raskt på flat mark eller i slak motbakke
Jeg er kortpustet når jeg går på flat mark med samme tempo som andre på min alder
Jeg blir kortpustet selv etter lett aktivitet, f.eks. når jeg vasker meg eller kler på meg
Jeg har pustevansker nesten hele tiden, selv i hvile
       med betydelig vanskelighet eller med hjelp fra andre
      omkring uten hjelp
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5. SØVN
Jeg er i stand til å sove normalt, dvs. jeg har ingen problemer med å sove
Jeg har lette søvnproblemer, f.eks. vanskelig for å falle i søvn eller våkner av og til om natten
Jeg har moderate søvnproblemer, f.eks. forstyrret søvn eller føler at jeg ikke har sovet nok
Jeg har store søvnproblemer, f.eks. må bruke sovmedisiner ofte eller rutinemessig, eller våkner om natten
Jeg lider av alvorlig søvnløshet, f.eks. er søvn nesten umulig selv med bruk av sovemedisiner,
6. SPISING
Jeg er i stand til å spise normalt, dvs. uten hjelp fra andre
Jeg er i stand til å spise selv med mindre vansker (f.eks. langsomt, klønete, skjelvende eller
Jeg trenger noe hjelp fra en annen person for å spise
Jeg er ute av stand til å spise selv i det hele tatt, slik at jeg må mates av en annen person
Jeg er ute av stand til å spise i det hele tatt, slik at jeg mates enten med slange eller intravenøst
7. TALE
Jeg er i stand til å tale normalt, dvs. klart, hørbart og flytende
Jeg har lette vansker med å snakke, f.eks. leter av og til etter ord, mumler eller endrer stemmeleiet
Jeg kan gjøre meg forstått, men min tale er f.eks. oppstykket, nølende, stotrende eller stammende
De fleste mennesker har store vansker med å forstå hva jeg sier
Jeg kan bare gjøre meg forstått med fakter
8. VANNLATING/AVFØRING
Min blære og tarm fungerer normalt og uten problemer
Jeg har lette problemer med min blære- og/eller tarmfunksjon, f.eks. vansker med å urinere eller
Jeg har betydelige problemer med min blære- og/eller tarmfunksjon, f.eks. "uhell" av og til,
Jeg har alvorlige problemer med min blære- og/eller tarmfunksjon, f.eks. regelmessige "uhell", eller behov
Jeg har ikke kontroll over min blære- og/eller tarmfunksjon
       og/eller for tidlig om morgenen
      med spesielle hjelpemidler)
      løs eller hard avføring
      eller alvorlig forstoppelse eller diaré
      for kateterisering eller klyster
       eller jeg forblir våken det meste av natten
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Jeg er i stand til å utføre mine vanlige aktiviteter (f.eks. arbeid, studier, husarbeid, fritidsaktiviteter
Jeg er i stand til å utføre mine vanlige aktiviteter noe mindre effektivt eller med litt vanskelighet
Jeg er i stand til å utføre mine vanlige aktiviteter mye mindre effektivt, med betydelig vanskelighet,
Jeg kan bare klare en liten del av mine vanlige aktiviteter fra tidligere
Jeg er ute av stand til å klare noen av mine vanlige aktiviteter fra tidligere
9. VANLIGE AKTIVITETER
Jeg er i stand til å tenke klart og logisk, og min hukommelse fungerer godt
Jeg har litt vansker med å tenke klart og logisk, eller min hukommelse svikter meg av og til
Jeg har merkbare vansker med å tenke klart og logisk, eller min hukommelse er noe redusert
Jeg har store vansker med å tenke klart og logisk, eller min hukommelse er betydelig nedsatt
Jeg er stadig forvirret og desorientert for sted og tid
10. MENTAL FUNKSJON
Jeg har ikke fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc
Jeg har lett fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc
Jeg har tydelig fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc
Jeg har alvorlig fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc
Jeg har uholdbart fysisk ubehag eller plager, f.eks. smerte, verk, kvalme, kløe, etc
11. UBEHAG OG SYMPTOMER
Jeg føler meg overhodet ikke trist, melankolsk eller deprimert
Jeg føler meg litt trist, melankolsk eller deprimert
Jeg føler meg middels trist, melankolsk eller deprimert
Jeg føler meg svært trist, melankolsk eller deprimert
Jeg føler meg ekstremt trist, melankolsk eller deprimert
12. DEPRESJON
       uten vanskeligheter)
        eller ikke fullt ut
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Jeg føler meg overhodet ikke engstelig, stresset eller nervøs
Jeg føler meg litt engstelig, stresset eller nervøs
Jeg føler meg middels engstelig, stresset eller nervøs
Jeg føler meg svært engstelig, stresset eller nervøs
Jeg føler meg ekstremt engstelig, stresset eller nervøs
13. STRESS
Jeg føler meg frisk og energisk
Jeg føler meg litt sliten, trett eller svak
Jeg føler meg middels sliten, trett eller svak
Jeg føler meg svært sliten, trett eller svak, nesten utslitt
Jeg føler meg ekstremt sliten, trett eller svak, totalt utslitt
14. LIVSKRAFT
Min helsetilstand har ingen ugunstig innvirkning på min seksuelle aktivitet
Min helsetilstand har en liten innvirkning på min seksuelle aktivitet
Min helsetilstand har en betydelig innvirkning på min seksuelle aktivitet
Min helsetilstand gjør seksuell aktivitet nesten umulig
Min helsetilstand gjør seksuell aktivitet umulig
15. SEKSUELL AKTIVITET
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